<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosgen</journal-id>
<journal-title-group>
<journal-title>PLoS Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7390</issn>
<issn pub-type="epub">1553-7404</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30586385</article-id>
<article-id pub-id-type="pmc">6324819</article-id>
<article-id pub-id-type="doi">10.1371/journal.pgen.1007535</article-id>
<article-id pub-id-type="publisher-id">PGENETICS-D-18-01324</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
<subj-group>
<subject>Developmental Neuroscience</subject>
<subj-group>
<subject>Neurodevelopmental Disorders</subject>
<subj-group>
<subject>Adhd</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Neurodevelopmental Disorders</subject>
<subj-group>
<subject>Adhd</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Neuropsychiatric Disorders</subject>
<subj-group>
<subject>Adhd</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Social Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Mood Disorders</subject>
<subj-group>
<subject>Bipolar Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Neuropsychiatric Disorders</subject>
<subj-group>
<subject>Anxiety Disorders</subject>
<subj-group>
<subject>Obsessive-Compulsive Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Neuroses</subject>
<subj-group>
<subject>Anxiety Disorders</subject>
<subj-group>
<subject>Obsessive-Compulsive Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Behavioral Disorders</subject>
<subj-group>
<subject>Obsessive-Compulsive Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Complexity</subject>
<subj-group>
<subject>Introns</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Complexity</subject>
<subj-group>
<subject>Introns</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Mental Health and Psychiatry</subject>
<subj-group>
<subject>Schizophrenia</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
<subj-group>
<subject>Autism</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Social Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
<subj-group>
<subject>Autism</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
<subj-group>
<subject>Developmental Neuroscience</subject>
<subj-group>
<subject>Neurodevelopmental Disorders</subject>
<subj-group>
<subject>Autism</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Neurology</subject>
<subj-group>
<subject>Neurodevelopmental Disorders</subject>
<subj-group>
<subject>Autism</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
<subj-group>
<subject>Cognitive Science</subject>
<subj-group>
<subject>Cognitive Psychology</subject>
<subj-group>
<subject>Language</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Cognitive Psychology</subject>
<subj-group>
<subject>Language</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Social Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Cognitive Psychology</subject>
<subj-group>
<subject>Language</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Comprehensive cross-disorder analyses of <italic>CNTNAP2</italic> suggest it is unlikely to be a primary risk gene for psychiatric disorders</article-title>
<alt-title alt-title-type="running-head">Role of <italic>CNTNAP2</italic> gene in psychiatry</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3901-7507</contrib-id>
<name>
<surname>Toma</surname>
<given-names>Claudio</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0636-4836</contrib-id>
<name>
<surname>Pierce</surname>
<given-names>Kerrie D.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>Alex D.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heath</surname>
<given-names>Anna</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mitchell</surname>
<given-names>Philip B.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2967-9662</contrib-id>
<name>
<surname>Schofield</surname>
<given-names>Peter R.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4014-4490</contrib-id>
<name>
<surname>Fullerton</surname>
<given-names>Janice M.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label>
<addr-line>Neuroscience Research Australia, Sydney, Australia</addr-line></aff>
<aff id="aff002"><label>2</label>
<addr-line>School of Medical Sciences, University of New South Wales, Sydney, Australia</addr-line></aff>
<aff id="aff003"><label>3</label>
<addr-line>School of Psychiatry, University of New South Wales, Sydney, Australia</addr-line></aff>
<aff id="aff004"><label>4</label>
<addr-line>Black Dog Institute, Prince of Wales Hospital, Sydney, Australia</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Barsh</surname>
<given-names>Gregory S.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>Stanford University School of Medicine, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email>c.toma@neura.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2018</year>
</pub-date>
<volume>14</volume>
<issue>12</issue>
<elocation-id>e1007535</elocation-id>
<history>
<date date-type="received">
<day>1</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 Toma et al</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Toma et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pgen.1007535.pdf"></self-uri>
<abstract>
<p>The contactin-associated protein-like 2 <italic>(CNTNAP2)</italic> gene is a member of the neurexin superfamily. <italic>CNTNAP2</italic> was first implicated in the cortical dysplasia-focal epilepsy (CDFE) syndrome, a recessive disease characterized by intellectual disability, epilepsy, language impairments and autistic features. Associated SNPs and heterozygous deletions in <italic>CNTNAP2</italic> were subsequently reported in autism, schizophrenia and other psychiatric or neurological disorders. We aimed to comprehensively examine evidence for the role of <italic>CNTNAP2</italic> in susceptibility to psychiatric disorders, by the analysis of multiple classes of genetic variation in large genomic datasets. In this study we used: i) summary statistics from the Psychiatric Genomics Consortium (PGC) GWAS for seven psychiatric disorders; ii) examined all reported <italic>CNTNAP2</italic> structural variants in patients and controls; iii) performed cross-disorder analysis of functional or previously associated SNPs; and iv) conducted burden tests for pathogenic rare variants using sequencing data (4,483 ASD and 6,135 schizophrenia cases, and 13,042 controls). The distribution of CNVs across <italic>CNTNAP2</italic> in psychiatric cases from previous reports was no different from controls of the database of genomic variants. Gene-based association testing did not implicate common variants in autism, schizophrenia or other psychiatric phenotypes. The association of proposed functional SNPs rs7794745 and rs2710102, reported to influence brain connectivity, was not replicated; nor did predicted functional SNPs yield significant results in meta-analysis across psychiatric disorders at either SNP-level or gene-level. Disrupting <italic>CNTNAP2</italic> rare variant burden was not higher in autism or schizophrenia compared to controls. Finally, in a CNV mircroarray study of an extended bipolar disorder family with 5 affected relatives we previously identified a 131kb deletion in <italic>CNTNAP2</italic> intron 1, removing a FOXP2 transcription factor binding site. Quantitative-PCR validation and segregation analysis of this CNV revealed imperfect segregation with BD.</p>
<p>This large comprehensive study indicates that <italic>CNTNAP2</italic> may not be a robust risk gene for psychiatric phenotypes.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Genetic mutations that disrupt both copies of the <italic>CNTNAP2</italic> gene lead to severe disease, characterized by profound intellectual disability, epilepsy, language difficulties and autistic traits, leading to the hypothesis that this gene may also be involved in autism given some overlapping clinical features with this disease. Indeed, several large DNA deletions affecting one of the two copies of <italic>CNTNAP2</italic> were found in some patients with autism, and later also in patients with schizophrenia, bipolar disorder, ADHD and epilepsy, suggesting that this gene was implicated in several psychiatric or neurologic diseases. Other studies considered genetic sequence variations that are common in the general population, and suggested that two such sequence variations in <italic>CNTNAP2</italic> predispose to psychiatric diseases by influencing the functionality and connectivity of the brain. To better understand the involvement of <italic>CNTNAP2</italic> in risk of mental illness, we performed several genetic analyses using a series of large publicly available or in-house datasets, comprising many thousands of patients and controls. Furthermore, we report the deletion of one copy of <italic>CNTNAP2</italic> in two patients with bipolar disorder and one unaffected relative from an extended family where five relatives were affected with this condition. Despite the previous consideration of <italic>CNTNAP2</italic> as a strong candidate gene for autism or schizophrenia, we show little evidence across multiple classes of DNA variation, that <italic>CNTNAP2</italic> is likely to play a major role in risk of psychiatric diseases.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000925</institution-id>
<institution>National Health and Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>1063960</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4014-4490</contrib-id>
<name>
<surname>Fullerton</surname>
<given-names>Janice M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000925</institution-id>
<institution>National Health and Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>1066177</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4014-4490</contrib-id>
<name>
<surname>Fullerton</surname>
<given-names>Janice M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000925</institution-id>
<institution>National Health and Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>1037196</award-id>
<principal-award-recipient>
<name>
<surname>Mitchell</surname>
<given-names>Philip B.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000925</institution-id>
<institution>National Health and Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>401184</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2967-9662</contrib-id>
<name>
<surname>Schofield</surname>
<given-names>Peter R.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This study was supported by the Australian National Medical and Health Research Council (NHMRC) Project Grants 1063960 and 1066177, and Program Grant 1037196. We gratefully acknowledge the Janette Mary O’Neil Research Fellowship (to JMF) and Mrs. Betty Lynch for supporting this work. DNA for the bipolar disorder family was extracted by Genetic Repositories Australia, an Enabling Facility that was supported by NHMRC Enabling Grant 401184. This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The authors report no biomedical financial interests or potential conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="6"></table-count>
<page-count count="21"></page-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2019-01-08</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>All relevant data are within the paper and its Supporting Information files.</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The contactin-associated protein-like 2 (<italic>CNTNAP2</italic>) is located on chromosome 7q35-36.1, and consists of 24 exons spanning 2.3Mb, making it one of the largest protein coding genes in the human genome. This gene encodes the CASPR2 protein, related to the neurexin superfamily, which localises with potassium channels at the juxtaparanodal regions of the Ravier nodes in myelinated axons, playing a crucial role in the clustering of potassium channels required for conduction of axon potentials [<xref ref-type="bibr" rid="pgen.1007535.ref001">1</xref>]. <italic>CNTNAP2</italic> is expressed in the spinal cord, prefrontal and frontal cortex, striatum, thalamus and amygdala; this pattern of expression is preserved throughout the development and adulthood [<xref ref-type="bibr" rid="pgen.1007535.ref002">2</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref003">3</xref>]. Its function is related to neuronal migration, dendritic arborisation and synaptic transmission [<xref ref-type="bibr" rid="pgen.1007535.ref004">4</xref>]. The crucial role of <italic>CNTNAP2</italic> in the human brain became clear in 2006 when Strauss <italic>et al</italic>, reported homozygous mutations in Old Order Amish families segregating with a severe Mendelian condition, described as cortical dysplasia-focal epilepsy (CDFE) syndrome (OMIM 610042) [<xref ref-type="bibr" rid="pgen.1007535.ref005">5</xref>]. In 2009, additional patients with recessive mutations in <italic>CNTNAP2</italic> were reported, with clinical features resembling Pitt-Hopkins syndrome [<xref ref-type="bibr" rid="pgen.1007535.ref006">6</xref>]. To date 33 patients, mostly from consanguineous families, have been reported with homozygous or compound deletions and truncating mutations in <italic>CNTNAP2</italic> [<xref ref-type="bibr" rid="pgen.1007535.ref005">5</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref009">9</xref>], and are collectively described as having CASPR2 deficiency disorder [<xref ref-type="bibr" rid="pgen.1007535.ref007">7</xref>]. The common clinical features in this phenotype include severe intellectual disability (ID), seizures with age of onset at two years and concomitant speech impairments or language regression. The phenotype is often accompanied by dysmorphic features, autistic traits, psychomotor delay and focal cortical dysplasia.</p>
<p><italic>CNTNAP2</italic> is also thought to contribute to diverse phenotypes in patients with interstitial or terminal deletions at 7q35 and 7q36. Interstitial or terminal deletions encompassing <italic>CNTNAP2</italic> and several other genes have been described in individuals with ID, seizures, craniofacial anomalies, including microcephaly, short stature and absence of language [<xref ref-type="bibr" rid="pgen.1007535.ref010">10</xref>]. The severe language impairments observed in patients with homozygous mutations or karyotypic abnormalities involving <italic>CNTNAP2</italic> suggested a possible functional interaction with <italic>FOXP2</italic>, a gene for which heterozygous mutations lead to a monogenic form of language disorder [<xref ref-type="bibr" rid="pgen.1007535.ref011">11</xref>]. Interestingly, <italic>Vernes et al</italic>., found that the FOXP2 transcription factor has a binding site in intron 1 of <italic>CNTNAP2</italic>, regulating its expression [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>]. Considering that a large proportion of autistic patients show language impairments and most individuals with homozygous mutations in <italic>CNTNAP2</italic> manifest autistic features, several studies investigated the potential involvement of <italic>CNTNAP2</italic> in autism spectrum disorder (ASD). In particular, two pioneering studies showed that single nucleotide polymorphism (SNP) markers rs2710102 and rs7794745 were associated with risk of ASD [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref014">14</xref>]. These studies were the first implicating <italic>CNTNAP2</italic> in autism, and opened a chapter of additional analyses in ASD and other psychiatric phenotypes during the next decade. In subsequent studies, rs2710102 was implicated in early language acquisition in the general population [<xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>], and showed functional effects on brain activation in neuroimaging studies [<xref ref-type="bibr" rid="pgen.1007535.ref016">16</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref019">19</xref>]. Furthermore, genotypes at rs7794745 were associated with reduced grey matter volume in the left superior occipital gyrus in two independent studies [<xref ref-type="bibr" rid="pgen.1007535.ref020">20</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref021">21</xref>], and alleles of this SNP were reported to affect voice-specific brain function [<xref ref-type="bibr" rid="pgen.1007535.ref022">22</xref>]. Genetic associations with ASD for these, and several other SNPs in <italic>CNTNAP2</italic>, have been reported in a number of studies [<xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref028">28</xref>]. Along with the first reports of SNPs associated with ASD, copy number variant (CNV) deletions have also been described in ID or ASD patients, which were proposed to be highly penetrant disease-causative mutations [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref029">29</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref038">38</xref>]. To better understand the role of <italic>CNTNAP2</italic> in ASD pathophysiology, knockout mice were generated. Studies of these mice reported several neuronal defects when both copies of <italic>CNTNAP2</italic> are mutated: abnormal neuronal migration, reduction of GABAergic interneurons, deficiency in excitatory neurotransmission, and the delay of myelination in the neocortex [<xref ref-type="bibr" rid="pgen.1007535.ref002">2</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref039">39</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref040">40</xref>].</p>
<p>These intriguing findings prompted additional investigations of <italic>CNTNAP2</italic> across other psychiatric disorders or language-related traits, with additional reports of SNPs being associated with schizophrenia (SCZ), bipolar disorder (BD), specific language impairment (SLI) and several other phenotypes or traits [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref041">41</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref050">50</xref>]. Consequently, other studies reported CNV deletions in <italic>CNTNAP2</italic> in schizophrenia [<xref ref-type="bibr" rid="pgen.1007535.ref051">51</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref052">52</xref>], bipolar disorder [<xref ref-type="bibr" rid="pgen.1007535.ref052">52</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref054">54</xref>], and ADHD [<xref ref-type="bibr" rid="pgen.1007535.ref055">55</xref>]; but also in neurological disorders, especially epilepsy [<xref ref-type="bibr" rid="pgen.1007535.ref056">56</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref061">61</xref>], and language-related phenotypes [<xref ref-type="bibr" rid="pgen.1007535.ref062">62</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref065">65</xref>]. Interestingly, several of these structural variants were found in intron 1 of <italic>CNTNAP2</italic>, encompassing the FOXP2 transcription factor binding site. Epilepsy is clinically frequent in psychiatric disorders, especially schizophrenia and bipolar disorder [<xref ref-type="bibr" rid="pgen.1007535.ref066">66</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref069">69</xref>], and is present in approximately 20% of autistic patients [<xref ref-type="bibr" rid="pgen.1007535.ref070">70</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref071">71</xref>]. Similarly, cognitive deficits involving language-related domains are also comorbid traits in schizophrenia and bipolar disorder [<xref ref-type="bibr" rid="pgen.1007535.ref067">67</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref072">72</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref074">74</xref>], and are common clinical features in ASD [<xref ref-type="bibr" rid="pgen.1007535.ref075">75</xref>], with many ASD patients remaining non-verbal throughout life [<xref ref-type="bibr" rid="pgen.1007535.ref075">75</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref076">76</xref>].</p>
<p>While <italic>CNTNAP2</italic> is now considered a strong candidate gene for ASD and psychiatric disease more generally (summarised in <xref ref-type="table" rid="pgen.1007535.t001">Table 1</xref>), several of these early supportive studies were performed with limited sample sizes, or were individual case reports which lacked comparison with control individuals, hence providing circumstantial evidence as a psychiatric risk gene. We therefore aimed in this current study to perform systematic genetic analyses with large datasets to examine the evidence for a role of the <italic>CNTNAP2</italic> gene in multiple psychiatric phenotypes–performing a comprehensive analysis of common and rare variants, CNVs and <italic>de novo</italic> mutations–using both publicly available datasets and in-house data.</p>
<table-wrap id="pgen.1007535.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.t001</object-id>
<label>Table 1</label>
<caption>
<title>Overview of studies implicating common alleles, structural variants or rare variants of <italic>CNTNAP2</italic> in psychiatric disorders.</title>
</caption>
<alternatives>
<graphic id="pgen.1007535.t001g" xlink:href="pgen.1007535.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">Psychiatric phenotype</th>
<th align="center" colspan="1" rowspan="1">Variant described</th>
<th align="center" colspan="1" rowspan="1">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Autism Spectrum Disorder</td>
<td align="left" colspan="1" rowspan="1">Associated SNP</td>
<td align="left" colspan="1" rowspan="1">Alarcon et al., 2008 [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>]; Arking et al., 2008 [<xref ref-type="bibr" rid="pgen.1007535.ref014">14</xref>]; Steer et al., 2010 [<xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>]; Anney et al., 2012 [<xref ref-type="bibr" rid="pgen.1007535.ref027">27</xref>]; Sampath et al., 2013 [<xref ref-type="bibr" rid="pgen.1007535.ref026">26</xref>]; Poot, 2014 [<xref ref-type="bibr" rid="pgen.1007535.ref028">28</xref>]; Chiocchetti et al., 2015 [<xref ref-type="bibr" rid="pgen.1007535.ref025">25</xref>]; Nascimento et al., 2016 [<xref ref-type="bibr" rid="pgen.1007535.ref024">24</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CNV deletion</td>
<td align="left" colspan="1" rowspan="1">Alarcon et al., 2008 [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>]; Poot et al., 2010 [<xref ref-type="bibr" rid="pgen.1007535.ref034">34</xref>]; Nord et al., 2011 [<xref ref-type="bibr" rid="pgen.1007535.ref037">37</xref>]; Girirajan et al., 2013 [<xref ref-type="bibr" rid="pgen.1007535.ref035">35</xref>]; Egger et al., 2014 [<xref ref-type="bibr" rid="pgen.1007535.ref038">38</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CNV duplication</td>
<td align="left" colspan="1" rowspan="1">Prasad et al., 2012 [<xref ref-type="bibr" rid="pgen.1007535.ref036">36</xref>]; Girirajan et al., 2013 [<xref ref-type="bibr" rid="pgen.1007535.ref035">35</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Rearrangement (Inversion)</td>
<td align="left" colspan="1" rowspan="1">Bakkaloglu et al., 2008 [<xref ref-type="bibr" rid="pgen.1007535.ref033">33</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">Rare variants</td>
<td align="left" colspan="1" rowspan="1">Bakkaloglu et al., 2008 [<xref ref-type="bibr" rid="pgen.1007535.ref033">33</xref>]; Chiocchetti et al., 2015 [<xref ref-type="bibr" rid="pgen.1007535.ref025">25</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1">Associated SNP</td>
<td align="left" colspan="1" rowspan="1">Wang et al., 2010 [<xref ref-type="bibr" rid="pgen.1007535.ref041">41</xref>]; Ji et al., 2013 [<xref ref-type="bibr" rid="pgen.1007535.ref049">49</xref>]; Chen et al. 2015, [<xref ref-type="bibr" rid="pgen.1007535.ref045">45</xref>];</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CNV deletion</td>
<td align="left" colspan="1" rowspan="1">Malhotra et al., 2011 [<xref ref-type="bibr" rid="pgen.1007535.ref052">52</xref>]; Friedman et al., 2008 [<xref ref-type="bibr" rid="pgen.1007535.ref051">51</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Bipolar Disorder</td>
<td align="left" colspan="1" rowspan="1">Associated SNP</td>
<td align="left" colspan="1" rowspan="1">Wang et al., 2010 [<xref ref-type="bibr" rid="pgen.1007535.ref041">41</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CNV deletion</td>
<td align="left" colspan="1" rowspan="1">Zhang et al., 2009 [<xref ref-type="bibr" rid="pgen.1007535.ref053">53</xref>]; Malhotra et al., 2011 [<xref ref-type="bibr" rid="pgen.1007535.ref052">52</xref>]; Lee et al., 2015 [<xref ref-type="bibr" rid="pgen.1007535.ref054">54</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">CNV duplication</td>
<td align="left" colspan="1" rowspan="1">Malhotra et al., [<xref ref-type="bibr" rid="pgen.1007535.ref052">52</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Attention Deficit Hyperactivity Disorder</td>
<td align="left" colspan="1" rowspan="1">CNV duplication</td>
<td align="left" colspan="1" rowspan="1">Elia et al., 2010 [<xref ref-type="bibr" rid="pgen.1007535.ref055">55</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Major Depressive Disorder</td>
<td align="left" colspan="1" rowspan="1">Associated SNP</td>
<td align="left" colspan="1" rowspan="1">Ji et al., 2013 [<xref ref-type="bibr" rid="pgen.1007535.ref049">49</xref>]; Wray et al., 2012 [<xref ref-type="bibr" rid="pgen.1007535.ref044">44</xref>].</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Alcohol dependence</td>
<td align="left" colspan="1" rowspan="1">Associated SNP</td>
<td align="left" colspan="1" rowspan="1">Zhong et al., 2005 [<xref ref-type="bibr" rid="pgen.1007535.ref042">42</xref>].</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Analysis of <italic>CNTNAP2</italic> common single nucleotide variation in the susceptibility of psychiatric disorders</title>
<p>During the last decade, several association studies have been performed to assess the role of common variants of <italic>CNTNAP2</italic> in autism or speech-related phenotypes [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref028">28</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref046">46</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref048">48</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref050">50</xref>], as well as several other psychiatric phenotypes [<xref ref-type="bibr" rid="pgen.1007535.ref041">41</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref045">45</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref049">49</xref>]. In <xref ref-type="table" rid="pgen.1007535.t002">Table 2</xref>, we summarise all markers found significantly associated in these previous studies, and report the corresponding <italic>P-value</italic> from the Psychiatric Genomics Consortium GWAS for seven major psychiatric disorders: ADHD, anorexia nervosa, ASD, bipolar disorder, MDD, OCD and schizophrenia. Nominal associations were found with ASD for the following markers: rs802524 (<italic>P</italic> = 0.016), rs802568 (<italic>P</italic> = 0.008), rs17170073 (<italic>P</italic> = 0.008), and rs2710102 (<italic>P</italic> = 0.036; which is highly correlated with 4 SNPs: rs759178, rs1922892, rs2538991, rs2538976). Furthermore, nominal association was also observed with schizophrenia for rs1859547 (<italic>P</italic> = 0.044); with ADHD for rs1718101 (<italic>P</italic> = 0.038); with MDD for rs12670868 (<italic>P</italic> = 0.047), rs17236239 (<italic>P</italic> = 0.006), rs4431523 (<italic>P</italic> = 0.001); and with anorexia nervosa for rs700273 (<italic>P</italic> = 0.013). The nominal association with ASD at rs1770073 and rs2710102 represents the only case in which the association in the original report replicates in the PGC dataset for the same phenotype. The two SNPs rs7794745 and rs2710102, which were repeatedly reported as being associated in earlier studies with smaller sample size and proposed to be functional SNPs, were not strongly associated with any phenotype (the most significant signal being <italic>P</italic> = 0.036 for rs2710102 in ASD). None of those associations survived corrections for multiple comparisons (<xref ref-type="table" rid="pgen.1007535.t002">Table 2</xref>).</p>
<table-wrap id="pgen.1007535.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.t002</object-id>
<label>Table 2</label>
<caption>
<title>Common SNPs in <italic>CNTNAP2</italic> previously reported to be associated in psychiatric diseases, and their evidence for association in PGC datasets.</title>
</caption>
<alternatives>
<graphic id="pgen.1007535.t002g" xlink:href="pgen.1007535.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="center" colspan="7" rowspan="1">PGC Association Results (<italic>P-Value</italic>)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">SNP</th>
<th align="left" colspan="1" rowspan="1">Location</th>
<th align="left" colspan="1" rowspan="1">Disease (Ref)</th>
<th align="center" colspan="1" rowspan="1">ASD</th>
<th align="center" colspan="1" rowspan="1">SCZ</th>
<th align="center" colspan="1" rowspan="1">BD</th>
<th align="center" colspan="1" rowspan="1">ADHD</th>
<th align="center" colspan="1" rowspan="1">MDD</th>
<th align="center" colspan="1" rowspan="1">AN</th>
<th align="center" colspan="1" rowspan="1">OCD</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">rs34712024</td>
<td align="left" colspan="1" rowspan="1">Promoter</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref025">25</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.672<xref ref-type="table-fn" rid="t002fn004">^</xref></td>
<td align="center" colspan="1" rowspan="1">0.45</td>
<td align="center" colspan="1" rowspan="1">0.099</td>
<td align="center" colspan="1" rowspan="1">0.442</td>
<td align="center" colspan="1" rowspan="1">N/A</td>
<td align="center" colspan="1" rowspan="1">0.283</td>
<td align="center" colspan="1" rowspan="1">0.295</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs802524</td>
<td align="left" colspan="1" rowspan="1">Intron 1</td>
<td align="left" colspan="1" rowspan="1">SCZ, BD [<xref ref-type="bibr" rid="pgen.1007535.ref041">41</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.016</bold>
<xref ref-type="table-fn" rid="t002fn004">^</xref>
</td>
<td align="center" colspan="1" rowspan="1">0.081</td>
<td align="center" colspan="1" rowspan="1">0.058</td>
<td align="center" colspan="1" rowspan="1">0.210</td>
<td align="center" colspan="1" rowspan="1">0.070</td>
<td align="center" colspan="1" rowspan="1">0.143</td>
<td align="center" colspan="1" rowspan="1">0.039</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs802568</td>
<td align="left" colspan="1" rowspan="1">Intron 1</td>
<td align="left" colspan="1" rowspan="1">SCZ, BD [<xref ref-type="bibr" rid="pgen.1007535.ref041">41</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.008</bold>
<xref ref-type="table-fn" rid="t002fn004">^</xref>
</td>
<td align="center" colspan="1" rowspan="1">0.061</td>
<td align="center" colspan="1" rowspan="1">0.312</td>
<td align="center" colspan="1" rowspan="1">0.047</td>
<td align="center" colspan="1" rowspan="1">0.054</td>
<td align="center" colspan="1" rowspan="1">0.321</td>
<td align="center" colspan="1" rowspan="1">0.279</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17170073</td>
<td align="left" colspan="1" rowspan="1">Intron 1</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref026">26</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.008</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.903</td>
<td align="center" colspan="1" rowspan="1">0.558</td>
<td align="center" colspan="1" rowspan="1">0.883</td>
<td align="center" colspan="1" rowspan="1">0.306</td>
<td align="center" colspan="1" rowspan="1">0.031</td>
<td align="center" colspan="1" rowspan="1">0.101</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1718101</td>
<td align="left" colspan="1" rowspan="1">Intron 1</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref027">27</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.076<xref ref-type="table-fn" rid="t002fn004">^</xref></td>
<td align="center" colspan="1" rowspan="1">0.257</td>
<td align="center" colspan="1" rowspan="1">0.215</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.038</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.255</td>
<td align="center" colspan="1" rowspan="1">0.243</td>
<td align="center" colspan="1" rowspan="1">0.029</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs700273</td>
<td align="left" colspan="1" rowspan="1">Intron 1</td>
<td align="left" colspan="1" rowspan="1">ALD [<xref ref-type="bibr" rid="pgen.1007535.ref042">42</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.840</td>
<td align="center" colspan="1" rowspan="1">0.655</td>
<td align="center" colspan="1" rowspan="1">0.837</td>
<td align="center" colspan="1" rowspan="1">0.544</td>
<td align="center" colspan="1" rowspan="1">0.338</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.013</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.554</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<underline>
<italic toggle="yes">rs7794745</italic>
</underline>
</td>
<td align="left" colspan="1" rowspan="1">Intron 2</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref014">14</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref024">24</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.906</td>
<td align="center" colspan="1" rowspan="1">0.734</td>
<td align="center" colspan="1" rowspan="1">0.498</td>
<td align="center" colspan="1" rowspan="1">0.393</td>
<td align="center" colspan="1" rowspan="1">0.173</td>
<td align="center" colspan="1" rowspan="1">0.877</td>
<td align="center" colspan="1" rowspan="1">0.503</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10251794</td>
<td align="left" colspan="1" rowspan="1">Intron 3</td>
<td align="left" colspan="1" rowspan="1">OPN [<xref ref-type="bibr" rid="pgen.1007535.ref043">43</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.301</td>
<td align="center" colspan="1" rowspan="1">0.365</td>
<td align="center" colspan="1" rowspan="1">0.155</td>
<td align="center" colspan="1" rowspan="1">0.452</td>
<td align="center" colspan="1" rowspan="1"><bold>0.047</bold> (rs12670868)</td>
<td align="center" colspan="1" rowspan="1">0.648</td>
<td align="center" colspan="1" rowspan="1">0.351</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs7804520</td>
<td align="left" colspan="1" rowspan="1">Intron 3</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref028">28</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.378</td>
<td align="center" colspan="1" rowspan="1">0.277</td>
<td align="center" colspan="1" rowspan="1">0.236</td>
<td align="center" colspan="1" rowspan="1">0.155</td>
<td align="center" colspan="1" rowspan="1">0.568</td>
<td align="center" colspan="1" rowspan="1">0.506</td>
<td align="center" colspan="1" rowspan="1">0.682</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1603450</td>
<td align="left" colspan="1" rowspan="1">Intron 8</td>
<td align="left" colspan="1" rowspan="1">LAN [<xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.445</td>
<td align="center" colspan="1" rowspan="1">0.166</td>
<td align="center" colspan="1" rowspan="1">0.643</td>
<td align="center" colspan="1" rowspan="1">0.141</td>
<td align="center" colspan="1" rowspan="1">0.010</td>
<td align="center" colspan="1" rowspan="1">0.951</td>
<td align="center" colspan="1" rowspan="1">0.577</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs826824</td>
<td align="left" colspan="1" rowspan="1">Intron 9</td>
<td align="left" colspan="1" rowspan="1">MDD (male only) [<xref ref-type="bibr" rid="pgen.1007535.ref044">44</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.218</td>
<td align="center" colspan="1" rowspan="1">0.181</td>
<td align="center" colspan="1" rowspan="1">0.256</td>
<td align="center" colspan="1" rowspan="1">0.317</td>
<td align="center" colspan="1" rowspan="1">0.266</td>
<td align="center" colspan="1" rowspan="1">0.736</td>
<td align="center" colspan="1" rowspan="1">0.199</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1859547</td>
<td align="left" colspan="1" rowspan="1">Intron 11</td>
<td align="left" colspan="1" rowspan="1">SCZ [<xref ref-type="bibr" rid="pgen.1007535.ref045">45</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.697</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.044</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.431</td>
<td align="center" colspan="1" rowspan="1">0.225</td>
<td align="center" colspan="1" rowspan="1">0.939</td>
<td align="center" colspan="1" rowspan="1">0.729</td>
<td align="center" colspan="1" rowspan="1">0.154</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs851715<xref ref-type="table-fn" rid="t002fn002"><sup><bold>&amp;</bold></sup></xref></td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.448</td>
<td align="center" colspan="1" rowspan="1">0.496</td>
<td align="center" colspan="1" rowspan="1">0.572</td>
<td align="center" colspan="1" rowspan="1">0.067</td>
<td align="center" colspan="1" rowspan="1">0.601</td>
<td align="center" colspan="1" rowspan="1">0.920</td>
<td align="center" colspan="1" rowspan="1">0.411</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10246256<xref ref-type="table-fn" rid="t002fn002"><sup><bold>&amp;</bold></sup></xref></td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref046">46</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.429</td>
<td align="center" colspan="1" rowspan="1">0.613</td>
<td align="center" colspan="1" rowspan="1">0.508</td>
<td align="center" colspan="1" rowspan="1">0.070</td>
<td align="center" colspan="1" rowspan="1">0.601 (rs851715)</td>
<td align="center" colspan="1" rowspan="1">0.871</td>
<td align="center" colspan="1" rowspan="1">0.454</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<underline>
<italic toggle="yes">rs2710102</italic>
</underline>
<xref ref-type="table-fn" rid="t002fn003">
<sup>
<bold>
<italic>#</italic>
</bold>
</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">ASD, SLI, DYS, SM, ANX, LAN, MDD [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref046">46</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref049">49</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.036</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.893</td>
<td align="center" colspan="1" rowspan="1">0.801</td>
<td align="center" colspan="1" rowspan="1">0.911</td>
<td align="center" colspan="1" rowspan="1">0.346</td>
<td align="center" colspan="1" rowspan="1">0.383</td>
<td align="center" colspan="1" rowspan="1">0.351</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs759178<xref ref-type="table-fn" rid="t002fn003"><sup><bold><italic>#</italic></bold></sup></xref></td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI, LAN [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.037</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.890</td>
<td align="center" colspan="1" rowspan="1">0.799</td>
<td align="center" colspan="1" rowspan="1">0.929</td>
<td align="center" colspan="1" rowspan="1">0.332</td>
<td align="center" colspan="1" rowspan="1">0.363</td>
<td align="center" colspan="1" rowspan="1">0.347</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1922892<xref ref-type="table-fn" rid="t002fn003"><sup><bold><italic>#</italic></bold></sup></xref></td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.039</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.908</td>
<td align="center" colspan="1" rowspan="1">0.794</td>
<td align="center" colspan="1" rowspan="1">0.940</td>
<td align="center" colspan="1" rowspan="1">0.332 (rs759178)</td>
<td align="center" colspan="1" rowspan="1">0.359</td>
<td align="center" colspan="1" rowspan="1">0.346</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2538991<xref ref-type="table-fn" rid="t002fn003"><sup><bold><italic>#</italic></bold></sup></xref></td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>]</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.041</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.852</td>
<td align="center" colspan="1" rowspan="1">0.797</td>
<td align="center" colspan="1" rowspan="1">0.989</td>
<td align="center" colspan="1" rowspan="1">0.332 (rs759178)</td>
<td align="center" colspan="1" rowspan="1">0.366</td>
<td align="center" colspan="1" rowspan="1">0.338</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17236239</td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">ASD, SCZ, SLI [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref027">27</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref046">46</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref049">49</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.142</td>
<td align="center" colspan="1" rowspan="1">0.290</td>
<td align="center" colspan="1" rowspan="1">0.278</td>
<td align="center" colspan="1" rowspan="1">0.883</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.006</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.622</td>
<td align="center" colspan="1" rowspan="1">0.954</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2538976<xref ref-type="table-fn" rid="t002fn003"><sup><bold><italic>#</italic></bold></sup></xref></td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI, SSD [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref050">50</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.051</td>
<td align="center" colspan="1" rowspan="1">0.718</td>
<td align="center" colspan="1" rowspan="1">0.692</td>
<td align="center" colspan="1" rowspan="1">0.812</td>
<td align="center" colspan="1" rowspan="1">0.358</td>
<td align="center" colspan="1" rowspan="1">0.408</td>
<td align="center" colspan="1" rowspan="1">0.424</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2215798</td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref026">26</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.5</td>
<td align="center" colspan="1" rowspan="1">0.469</td>
<td align="center" colspan="1" rowspan="1">0.361</td>
<td align="center" colspan="1" rowspan="1">0.742</td>
<td align="center" colspan="1" rowspan="1">0.030</td>
<td align="center" colspan="1" rowspan="1">0.568</td>
<td align="center" colspan="1" rowspan="1">0.281</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs4431523</td>
<td align="left" colspan="1" rowspan="1">Intron 13</td>
<td align="left" colspan="1" rowspan="1">SLI [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.275</td>
<td align="center" colspan="1" rowspan="1">0.844</td>
<td align="center" colspan="1" rowspan="1">0.676</td>
<td align="center" colspan="1" rowspan="1">0.614</td>
<td align="center" colspan="1" rowspan="1"><bold>0.001</bold> (rs2708267)</td>
<td align="center" colspan="1" rowspan="1">0.933</td>
<td align="center" colspan="1" rowspan="1">0.972</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2710117</td>
<td align="left" colspan="1" rowspan="1">Intron 14</td>
<td align="left" colspan="1" rowspan="1">SLI, MDD [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref046">46</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref049">49</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.1477</td>
<td align="center" colspan="1" rowspan="1">0.6701</td>
<td align="center" colspan="1" rowspan="1">0.7566</td>
<td align="center" colspan="1" rowspan="1">0.2106</td>
<td align="center" colspan="1" rowspan="1">0.894 (rs2710121)</td>
<td align="center" colspan="1" rowspan="1">0.993</td>
<td align="center" colspan="1" rowspan="1">0.321</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2710093</td>
<td align="left" colspan="1" rowspan="1">Intron 14</td>
<td align="left" colspan="1" rowspan="1">ASD [<xref ref-type="bibr" rid="pgen.1007535.ref026">26</xref>]</td>
<td align="center" colspan="1" rowspan="1">0.4077</td>
<td align="center" colspan="1" rowspan="1">0.2891</td>
<td align="center" colspan="1" rowspan="1">0.02819</td>
<td align="center" colspan="1" rowspan="1">0.2943</td>
<td align="center" colspan="1" rowspan="1">0.090 (rs2710091)</td>
<td align="center" colspan="1" rowspan="1">0.8416</td>
<td align="center" colspan="1" rowspan="1">0.2767</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p>The disease for which association at each listed SNP is given, along with the reference number for each study and the approximate location of each variant within the <italic>CNTNAP2</italic> gene structure. On the right, the <italic>P-value</italic> from each Psychiatric Genomics Consortium (PGC) dataset is reported. Where the associated SNP was not found in the GWAS summary statistic data, results for an alternative SNP are shown in parenthesis (r<sup>2</sup> = 1). Putative functional SNPs rs7794745 and rs2710102 are underlined. No association survives correction for multiple independent tests (<italic>P</italic> &lt;3.8E-04), but <italic>P-values</italic> &lt; 0.05 are shown in bold. Abbreviations: ASD, autism spectrum disorder; SLI, specific language impairment; DYS, dyslexia; ANX, social anxiety; LAN, language in general population; SCZ, schizophrenia; BD, bipolar disorder; ALD, Alcohol dependence; OPN, Openness general population; MDD, major depressive disorder; SSD, speech sound disorder; N/A, SNP not genotyped</p>
</fn>
<fn id="t002fn002">
<p>&amp;, r<sup>2</sup>&gt;0.97 across the following SNPs: rs851715 and rs10246256</p>
</fn>
<fn id="t002fn003">
<p>#, r<sup>2</sup>&gt;0.97 across the following SNPs: rs2710102, rs759178, rs1922892, rs2538991 and rs2538976</p>
</fn>
<fn id="t002fn004">
<p>^, summary data at this SNP was not included in the latest autism GWAS (PGC2) but was present in the previous data set which included 5,305 ASD cases and 5,305 controls.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec004">
<title>Gene-based analysis of cross-disorder associations</title>
<p>Next, we explored the contribution of common variants across <italic>CNTNAP2</italic> by performing a gene-based association study in MAGMA using GWAS summary statistics from PGC data of seven psychiatric disorders in European populations (<xref ref-type="table" rid="pgen.1007535.t003">Table 3</xref>). Association plots for all SNPs included in analysis of each individual phenotype are shown in supporting information (<xref ref-type="supplementary-material" rid="pgen.1007535.s001">S1 Fig</xref>).</p>
<table-wrap id="pgen.1007535.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.t003</object-id>
<label>Table 3</label>
<caption>
<title>Gene-based tests for association of <italic>CNTNAP2</italic> across seven psychiatric disorders using GWAS summary statistics of the PGC data sets.</title>
</caption>
<alternatives>
<graphic id="pgen.1007535.t003g" xlink:href="pgen.1007535.t003"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Disease</th>
<th align="center" colspan="1" rowspan="1">N Cases–Controls</th>
<th align="center" colspan="1" rowspan="1">N SNPs tested</th>
<th align="center" colspan="1" rowspan="1">Gene-based <italic>P-value</italic></th>
<th align="center" colspan="1" rowspan="1">Top SNP</th>
<th align="center" colspan="1" rowspan="1">Top SNP <italic>P-value</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">ADHD<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">19,099–34,194</td>
<td align="center" colspan="1" rowspan="1">7,538</td>
<td align="center" colspan="1" rowspan="1">0.16</td>
<td align="center" colspan="1" rowspan="1">rs370840971</td>
<td align="center" colspan="1" rowspan="1">4.8E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AN<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">3,495–10,982</td>
<td align="center" colspan="1" rowspan="1">9,318</td>
<td align="center" colspan="1" rowspan="1">0.33</td>
<td align="center" colspan="1" rowspan="1">rs138287908</td>
<td align="center" colspan="1" rowspan="1">8.5E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ASD<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">6,197–7,377</td>
<td align="center" colspan="1" rowspan="1">5,946</td>
<td align="center" colspan="1" rowspan="1">0.54</td>
<td align="center" colspan="1" rowspan="1">rs1089600</td>
<td align="center" colspan="1" rowspan="1">0.0018</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BD<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">20,352–31,358</td>
<td align="center" colspan="1" rowspan="1">11,345</td>
<td align="center" colspan="1" rowspan="1">0.34</td>
<td align="center" colspan="1" rowspan="1">rs181471483</td>
<td align="center" colspan="1" rowspan="1">3.6E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MDD<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></td>
<td align="center" colspan="1" rowspan="1">9,240–9,519</td>
<td align="center" colspan="1" rowspan="1">1,214</td>
<td align="center" colspan="1" rowspan="1">
<bold><italic>0</italic>.<italic>029</italic></bold>
</td>
<td align="center" colspan="1" rowspan="1">rs4725752</td>
<td align="center" colspan="1" rowspan="1">9.3E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OCD<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">2,688–7,037</td>
<td align="center" colspan="1" rowspan="1">8,631</td>
<td align="center" colspan="1" rowspan="1">0.30</td>
<td align="center" colspan="1" rowspan="1">rs6976859</td>
<td align="center" colspan="1" rowspan="1">8.7E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCZ<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></td>
<td align="center" colspan="1" rowspan="1">33,640–43,456</td>
<td align="center" colspan="1" rowspan="1">12,264</td>
<td align="center" colspan="1" rowspan="1">0.11</td>
<td align="center" colspan="1" rowspan="1">rs78093069</td>
<td align="center" colspan="1" rowspan="1">1.1E-04</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p>The numbers (N) of cases and controls in each dataset examined are given, along with the number of SNPs tested in each dataset. The name and <italic>P-value</italic> of the SNP with most significant association is given. Abbreviations: ADHD, attention-deficit/hyperactivity disorder; AN, anorexia nervosa; ASD, Autism spectrum disorder; BD, bipolar disorder; MDD, major depressive disorder; OCD, obsessive compulsive disorder; SCZ, schizophrenia</p>
</fn>
<fn id="t003fn002">
<p><sup>a</sup>, European individuals from the PGC2 data sets</p>
</fn>
<fn id="t003fn003">
<p><sup>b</sup>, European individuals from the PGC1 data sets.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The test included a dense coverage of SNPs across <italic>CNTNAP2</italic>: from 1,214 SNPs in MDD up to 12,264 SNPs in schizophrenia. The results suggest that common variants overall do not contribute to disease susceptibility of these phenotypes (<xref ref-type="table" rid="pgen.1007535.t003">Table 3</xref>). The most significant association observed was for MDD phase 1 analysis (<italic>P</italic> = 0.029), which is the dataset with the most modest coverage of markers.</p>
<p>To explore whether any gene-based signal is not being detected due to a high signal-to-noise ratio (i.e. inclusion of a large number of SNPs of no functional consequence), we selected 63 predicted functional SNPs in <italic>CNTNAP2</italic> and performed a meta-analysis across psychiatric disorders (for regional association plot, see <xref ref-type="supplementary-material" rid="pgen.1007535.s002">S2 Fig</xref>). Nominal significance of association was observed for 11 predicted functional SNPs with <italic>P-values</italic> ranging from 0.01 and 0.05, but none survive correction for multiple comparisons (<xref ref-type="table" rid="pgen.1007535.t004">Table 4</xref>).</p>
<table-wrap id="pgen.1007535.t004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.t004</object-id>
<label>Table 4</label>
<caption>
<title>Cross psychiatric disorders meta-analysis of 63 predicted functional SNPs.</title>
</caption>
<alternatives>
<graphic id="pgen.1007535.t004g" xlink:href="pgen.1007535.t004"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">SNPs</th>
<th align="left" colspan="1" rowspan="1">Allele</th>
<th align="left" colspan="1" rowspan="1">Function</th>
<th align="left" colspan="1" rowspan="1">Datasets</th>
<th align="left" colspan="1" rowspan="1">I</th>
<th align="left" colspan="1" rowspan="1">
<italic>P-val</italic>
</th>
<th align="left" colspan="1" rowspan="1">OR</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">rs17480644</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">TFBS</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">8</td>
<td align="center" colspan="1" rowspan="1">0.083</td>
<td align="center" colspan="1" rowspan="1">1.039</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1260124</td>
<td align="left" colspan="1" rowspan="1">A/T</td>
<td align="left" colspan="1" rowspan="1">TFBS</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.635</td>
<td align="center" colspan="1" rowspan="1">0.996</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs35796336</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">TFBS</td>
<td align="left" colspan="1" rowspan="1">AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.049</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.027</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10277276</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">TFBS</td>
<td align="left" colspan="1" rowspan="1">BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.764</td>
<td align="center" colspan="1" rowspan="1">0.992</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs34712024</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">TFBS</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">32</td>
<td align="center" colspan="1" rowspan="1">0.626</td>
<td align="center" colspan="1" rowspan="1">1.012</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2462603</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">TFBS</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.303</td>
<td align="center" colspan="1" rowspan="1">0.993</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1639484</td>
<td align="left" colspan="1" rowspan="1">A/T</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.376</td>
<td align="center" colspan="1" rowspan="1">1.005</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs12703814</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.965</td>
<td align="center" colspan="1" rowspan="1">0.999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1639447</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.376</td>
<td align="center" colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs769344</td>
<td align="left" colspan="1" rowspan="1">C/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.778</td>
<td align="center" colspan="1" rowspan="1">0.996</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10280967</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.639</td>
<td align="center" colspan="1" rowspan="1">0.996</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10243142</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.738</td>
<td align="center" colspan="1" rowspan="1">1.002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs12535047</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.327</td>
<td align="center" colspan="1" rowspan="1">0.993</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs347201</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.089</td>
<td align="center" colspan="1" rowspan="1">1.011</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs13234249</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">0.101</td>
<td align="center" colspan="1" rowspan="1">1.011</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs12666908</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.914</td>
<td align="center" colspan="1" rowspan="1">0.999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs11972428</td>
<td align="left" colspan="1" rowspan="1">T/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.672</td>
<td align="center" colspan="1" rowspan="1">1.012</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs34222835</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">4</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.045</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.979</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10261412</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">52</td>
<td align="center" colspan="1" rowspan="1">0.808</td>
<td align="center" colspan="1" rowspan="1">0.995</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1826843</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">20</td>
<td align="center" colspan="1" rowspan="1">0.153</td>
<td align="center" colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17170356</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.137</td>
<td align="center" colspan="1" rowspan="1">0.972</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs4726831</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">18</td>
<td align="center" colspan="1" rowspan="1">0.294</td>
<td align="center" colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10279700</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">26</td>
<td align="center" colspan="1" rowspan="1">0.857</td>
<td align="center" colspan="1" rowspan="1">0.998</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs35701811</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.899</td>
<td align="center" colspan="1" rowspan="1">0.998</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs899617</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.026</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs747140</td>
<td align="left" colspan="1" rowspan="1">C/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.025</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs7798078</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.091</td>
<td align="center" colspan="1" rowspan="1">1.011</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs34592169</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">Splicing</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="center" colspan="1" rowspan="1">0.067</td>
<td align="center" colspan="1" rowspan="1">1.014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs6970064</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">7</td>
<td align="center" colspan="1" rowspan="1">0.462</td>
<td align="center" colspan="1" rowspan="1">1.004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17170640</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.018</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.041</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs16883690</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">BD, SCZ</td>
<td align="center" colspan="1" rowspan="1">66</td>
<td align="center" colspan="1" rowspan="1">0.673</td>
<td align="center" colspan="1" rowspan="1">1.066</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs7797724</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">BD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.047</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.592</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs851659</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">9</td>
<td align="center" colspan="1" rowspan="1">0.349</td>
<td align="center" colspan="1" rowspan="1">0.993</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs35815165</td>
<td align="left" colspan="1" rowspan="1">-/AA</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.831</td>
<td align="center" colspan="1" rowspan="1">1.002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs13247212</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.797</td>
<td align="center" colspan="1" rowspan="1">0.996</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1177007</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.238</td>
<td align="center" colspan="1" rowspan="1">1.008</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs12154883</td>
<td align="left" colspan="1" rowspan="1">T/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.645</td>
<td align="center" colspan="1" rowspan="1">1.006</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs13438769</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.057</td>
<td align="center" colspan="1" rowspan="1">1.018</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2707580</td>
<td align="left" colspan="1" rowspan="1">T/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.146</td>
<td align="center" colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2707581</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.156</td>
<td align="center" colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2141955</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.032</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.015</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs34347668</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.973</td>
<td align="center" colspan="1" rowspan="1">1.000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs4725756</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.015</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.984</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2888540</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.023</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17170789</td>
<td align="left" colspan="1" rowspan="1">A/T</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.566</td>
<td align="center" colspan="1" rowspan="1">1.010</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17170801</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.643</td>
<td align="center" colspan="1" rowspan="1">0.989</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10279343</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">0.568</td>
<td align="center" colspan="1" rowspan="1">1.014</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs1122622</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">66</td>
<td align="center" colspan="1" rowspan="1">0.745</td>
<td align="center" colspan="1" rowspan="1">1.026</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs5888312</td>
<td align="left" colspan="1" rowspan="1">-/A</td>
<td align="left" colspan="1" rowspan="1">SeqCons</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN</td>
<td align="center" colspan="1" rowspan="1">70</td>
<td align="center" colspan="1" rowspan="1">0.744</td>
<td align="center" colspan="1" rowspan="1">1.010</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs9648691</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">SeqCons, Splicing</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">64</td>
<td align="center" colspan="1" rowspan="1">0.806</td>
<td align="center" colspan="1" rowspan="1">1.002</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs987456</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">29</td>
<td align="center" colspan="1" rowspan="1">0.570</td>
<td align="center" colspan="1" rowspan="1">1.004</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2717809</td>
<td align="left" colspan="1" rowspan="1">C/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.746</td>
<td align="center" colspan="1" rowspan="1">0.989</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2530312</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">70</td>
<td align="center" colspan="1" rowspan="1">0.485</td>
<td align="center" colspan="1" rowspan="1">0.990</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs3194</td>
<td align="left" colspan="1" rowspan="1">A/C</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">68</td>
<td align="center" colspan="1" rowspan="1">0.797</td>
<td align="center" colspan="1" rowspan="1">1.003</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10243309</td>
<td align="left" colspan="1" rowspan="1">C/T</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">AN, MDD</td>
<td align="center" colspan="1" rowspan="1">15</td>
<td align="center" colspan="1" rowspan="1">0.125</td>
<td align="center" colspan="1" rowspan="1">1.149</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17170999</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">AN, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.026</bold>
</td>
<td align="center" colspan="1" rowspan="1">0.917</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2530311</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">66</td>
<td align="center" colspan="1" rowspan="1">0.975</td>
<td align="center" colspan="1" rowspan="1">0.999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17171000</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.583</td>
<td align="center" colspan="1" rowspan="1">0.988</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10251347</td>
<td align="left" colspan="1" rowspan="1">C/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.428</td>
<td align="center" colspan="1" rowspan="1">0.986</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2717829</td>
<td align="left" colspan="1" rowspan="1">C/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">50</td>
<td align="center" colspan="1" rowspan="1">0.820</td>
<td align="center" colspan="1" rowspan="1">0.997</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs10280038</td>
<td align="left" colspan="1" rowspan="1">A/G</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">AN, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">
<bold>0.031</bold>
</td>
<td align="center" colspan="1" rowspan="1">1.087</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2530310</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, ASD, BD, OCD, SCZ, MDD</td>
<td align="center" colspan="1" rowspan="1">67</td>
<td align="center" colspan="1" rowspan="1">0.666</td>
<td align="center" colspan="1" rowspan="1">0.994</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs17171006</td>
<td align="left" colspan="1" rowspan="1">T/C</td>
<td align="left" colspan="1" rowspan="1">miRNA</td>
<td align="left" colspan="1" rowspan="1">ADHD, AN, BD, OCD, SCZ</td>
<td align="center" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1">0.493</td>
<td align="center" colspan="1" rowspan="1">0.985</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001">
<p>For each predicted functional SNP, the alternative alleles and predicted function are listed. <italic>P-values</italic> (<italic>P-val</italic>) were calculated considering fixed-model effect, except SNPs with evidence of heterogeneity (I&gt;50) where odds ratios (OR) were considered under random-effects. Nominally significant associations are indicated in bold <italic>(P-values&lt;0</italic>.<italic>05)</italic>, but none exceed correction for multiple testing (<italic>P</italic>&lt;7.9E-04). Abbreviations: TFBS, transcription factor binding site; SeqCons, sequence conserved nucleotide across species; miRNA, predicted miRNA binding site; Splicing, exonic splicing enhancer (ESE).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The only predicted functional SNP which was previously reported as being associated with ASD was rs34712024 [<xref ref-type="bibr" rid="pgen.1007535.ref025">25</xref>], but this variant was not associated with autism in the PGC dataset (<italic>P</italic> = 0.67; <xref ref-type="table" rid="pgen.1007535.t002">Table 2</xref>), nor other psychiatric phenotypes examined separately or together (Tables <xref ref-type="table" rid="pgen.1007535.t002">2</xref>–<xref ref-type="table" rid="pgen.1007535.t004">4</xref>). MAGMA gene-based association analysis using this more restricted pool of common putative functional variants revealed significant association with ADHD after correction for multiple testing (corrected <italic>P-value</italic> = 0.033) and a nominal association with schizophrenia which did not survive multiple testing correction (<xref ref-type="supplementary-material" rid="pgen.1007535.s003">S1 Table</xref>). However, this signal is reduced to trend level in the cross-disorder meta-analysis for this functional SNP-set (<italic>P-value</italic> = 0.11; <xref ref-type="supplementary-material" rid="pgen.1007535.s003">S1 Table</xref>).</p>
</sec>
<sec id="sec005">
<title><italic>De novo</italic> variants in <italic>CNTNAP2</italic></title>
<p><italic>De novo</italic> variants in protein-coding genes which are predicted to be functionally damaging are considered to be highly pathogenic and have been extensively explored to implicate genes in psychiatric diseases, especially in ASD and schizophrenia [<xref ref-type="bibr" rid="pgen.1007535.ref077">77</xref>]. We explored publicly available sequence data from previous projects in psychiatric disorders to assess the rate of coding <italic>de novo</italic> variants in <italic>CNTNAP2</italic> using two databases (NPdenovo, <ext-link ext-link-type="uri" xlink:href="http://www.wzgenomics.cn/NPdenovo/">http://www.wzgenomics.cn/NPdenovo/</ext-link>; and denovo-db, <ext-link ext-link-type="uri" xlink:href="http://denovo-db.gs.washington.edu/denovo-db/">http://denovo-db.gs.washington.edu/denovo-db/</ext-link>). No truncating or missense variants were identified across <italic>CNTNAP2</italic> in 15,539 families (including 2,163 controls), and synonymous variants were reported in only two probands with developmental disorder (<xref ref-type="table" rid="pgen.1007535.t005">Table 5</xref>).</p>
<table-wrap id="pgen.1007535.t005" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.t005</object-id>
<label>Table 5</label>
<caption>
<title><italic>CNTNAP2 de novo</italic> variants identified across several disease-specific sequencing projects.</title>
</caption>
<alternatives>
<graphic id="pgen.1007535.t005g" xlink:href="pgen.1007535.t005"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="1">Phenotype</th>
<th align="center" colspan="1" rowspan="1">N Families</th>
<th align="center" colspan="1" rowspan="1">Intronic</th>
<th align="center" colspan="1" rowspan="1">Synonymous</th>
<th align="center" colspan="1" rowspan="1">Missense</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">ASD</td>
<td align="center" colspan="1" rowspan="1">6,171</td>
<td align="center" colspan="1" rowspan="1">106</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">SCZ</td>
<td align="center" colspan="1" rowspan="1">1,164</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">EE</td>
<td align="center" colspan="1" rowspan="1">647</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">ID</td>
<td align="center" colspan="1" rowspan="1">1,101</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">DD</td>
<td align="center" colspan="1" rowspan="1">4,293</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">2</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">Controls</td>
<td align="center" colspan="1" rowspan="1">2,163</td>
<td align="center" colspan="1" rowspan="1">13</td>
<td align="center" colspan="1" rowspan="1">-</td>
<td align="center" colspan="1" rowspan="1">-</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t005fn001">
<p>The number (N) of families in each dataset examined is given. The full list of <italic>de novo</italic> variants observed is listed in <xref ref-type="supplementary-material" rid="pgen.1007535.s004">S2 Table</xref>. Abbreviations: ASD, autism spectrum disorder; SCZ, schizophrenia; EE, epilepsy; ID, intellectual disability; DD, developmental disability.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec006">
<title>Pathogenic Ultra-Rare Variants (URV) of <italic>CNTNAP2</italic> in ASD and Schizophrenia</title>
<p>Finally, we explored the potential impact of pathogenic ultra-rare variants (URV) in <italic>CNTNAP2</italic> using available sequencing datasets of 4,483 patients with ASD and 6,135 patients with schizophrenia compared with 13,042 controls. We considered only those variants predicted to be pathogenic in both SIFT and Polyphen and which are ultra-rare (MAF&lt;0.0001 in Non-Finnish European population; <xref ref-type="supplementary-material" rid="pgen.1007535.s005">S3 Table</xref>). No difference in the total number of URV was observed between controls and patients with ASD (<italic>P</italic> = 0.11), or schizophrenia (<italic>P</italic> = 0.78) (<xref ref-type="table" rid="pgen.1007535.t006">Table 6</xref>).</p>
<table-wrap id="pgen.1007535.t006" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.t006</object-id>
<label>Table 6</label>
<caption>
<title>Burden analysis of <italic>CNTNAP2</italic> ultra-rare variants (URVs) in ASD and SCZ.</title>
</caption>
<alternatives>
<graphic id="pgen.1007535.t006g" xlink:href="pgen.1007535.t006"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">N Individuals</th>
<th align="left" colspan="1" rowspan="1">N Pathogenic URVs</th>
<th align="left" colspan="1" rowspan="1">
<italic>P-Value</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Controls</td>
<td align="center" colspan="1" rowspan="1">13,042</td>
<td align="center" colspan="1" rowspan="1">59</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCZ</td>
<td align="center" colspan="1" rowspan="1">6,135</td>
<td align="center" colspan="1" rowspan="1">26</td>
<td align="center" colspan="1" rowspan="1">0.78</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ASD</td>
<td align="center" colspan="1" rowspan="1">4,483</td>
<td align="center" colspan="1" rowspan="1">29</td>
<td align="center" colspan="1" rowspan="1">0.11</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t006fn001">
<p>The selection of variants included missense variants which are predicted to be pathogenic, truncating variants and canonical splice-site variants. The full list of URVs observed is provided in <xref ref-type="supplementary-material" rid="pgen.1007535.s005">S3 Table</xref>. Abbreviations: SCZ, schizophrenia; ASD, autism spectrum disorder.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec007">
<title>Structural variants affecting <italic>CNTNAP2</italic> amongst psychiatric phenotypes</title>
<p>Several deletions and duplications have been described in neuropsychiatric phenotypes thus far. In <xref ref-type="fig" rid="pgen.1007535.g001">Fig 1</xref>, we present a comprehensive representation of all previously reported structural variants found in <italic>CNTNAP2</italic> in psychiatric disorders such as ASD or ID [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref029">29</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref038">38</xref>], schizophrenia or bipolar disorder [<xref ref-type="bibr" rid="pgen.1007535.ref051">51</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref054">54</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref078">78</xref>], ADHD [<xref ref-type="bibr" rid="pgen.1007535.ref055">55</xref>], neurologic disorders such as epilepsy, Tourette syndrome or Charcot-Marie-Tooth [<xref ref-type="bibr" rid="pgen.1007535.ref056">56</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref061">61</xref>]; and finally language-related phenotypes such as speech delay, childhood apraxia of speech and dyslexia [<xref ref-type="bibr" rid="pgen.1007535.ref062">62</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref065">65</xref>]. Interestingly, the reported structural variants frequently map in intron 1, and extend to exon 4 in some cases. The distribution of those structural variants across different phenotypes does not vary with those found in control populations from the database of genomic variants (<ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv/app/home">http://dgv.tcag.ca/dgv/app/home</ext-link>) (<xref ref-type="fig" rid="pgen.1007535.g001">Fig 1</xref>), suggesting that structural variants in <italic>CNTNAP2</italic> are not rare events associated exclusively to disease but are present with rare frequency in the general population. Unfortunately, as many reported CNVs come from individual case reports for which the number of subjects screened is not reported, direct frequency comparisons of this data are not meaningful.</p>
<fig id="pgen.1007535.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Overview of heterozygous CNVs spanning the <italic>CNTNAP2</italic> gene across several diseases.</title>
<p>Abbreviations: ID (Intellectual disability), ASD (autism spectrum disorder), SCZ (schizophrenia), BD (bipolar disorder), ADHD (Attention-deficit/hyperactivity disorder), EP (epilepsy), TS (Tourette syndrome), CMT2 (axonal Charcot-Marie-Tooth), and SS (Speech spectrum: speech delay, childhood apraxia of speech and dyslexia). In parenthesis is reported the reference to each study. *, additional rearrangements reported in this patient. The dashed lines represent the exons and the upper box shows the position of the FOXP2 binding site. In dark shading, CNVs≥80kb found in the general populations from the Database of Genomic Variants are shown.</p>
</caption>
<graphic xlink:href="pgen.1007535.g001"></graphic>
</fig>
</sec>
<sec id="sec008">
<title>Examination of an intronic deletion in <italic>CNTNAP2</italic> in an extended family with bipolar disorder</title>
<p>CNV microarray analysis was previously performed in two affected individuals from an extended family which included five relatives affected with bipolar I disorder [<xref ref-type="bibr" rid="pgen.1007535.ref078">78</xref>]. A drop in signal intensity for 340 consecutive probes was compatible with a deletion of 131 kb in intron 1 of <italic>CNTNAP2</italic> (hg19/chr7:146203548–146334635; <xref ref-type="fig" rid="pgen.1007535.g002">Fig 2A</xref>), encompassing the described binding site for the transcription factor FOXP2 (hg19/chr7:146215016–146215040) [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>]. The deletion was detected in one of the two affected individuals examined by CNV array. To infer deletion segregation amongst additional relatives, WES-derived genotypes were used to create haplotypes across chromosome 7q35 (<xref ref-type="fig" rid="pgen.1007535.g002">Fig 2B</xref>). CNV segregation (by haplotype inference) was uninformative due to: 1) incomplete genotype data (unaffected descendants of deceased patient 8404 were not included in the WES study) and 2) a likely recombination at 7q35 in the family. Thus experimental validation and CNV genotyping was performed in all individuals with DNA available to assess the presence of the <italic>CNTNAP2</italic> intronic deletion and its disease association. Using quantitative PCR, the deletion was validated in proband subject 8401, and was detected in one unaffected descendant of deceased patient 8404 (<xref ref-type="fig" rid="pgen.1007535.g002">Fig 2B and 2C</xref>), implying that: 1) affected subject 8404 would have carried the deletion, had DNA been available; and 2) the CNV is unlikely to be highly penetrant as it was observed in an unaffected adult relative. The structural variant was not detected in the remaining affected relatives and therefore did not segregate with disease status in this family (<xref ref-type="fig" rid="pgen.1007535.g002">Fig 2B</xref>).</p>
<fig id="pgen.1007535.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007535.g002</object-id>
<label>Fig 2</label>
<caption>
<title>CNV deletion encompassing intron 1 of <italic>CNTNAP2</italic> in an extended family with bipolar disorder.</title>
<p>A) CytoScan HD array output image shows the position of the drop in signal intensity of 340 probes, indicating a deletion spanning 131kb (chr7:146203548–146334635; GRCh37/hg19) found in the patient 8401. The position of the FOXP2 binding site within the deletion is shown above. B) The bipolar pedigree includes five patients with bipolar disorder I (BPI) across two generations. Symbols: _, individuals with DNA available; &amp;, individuals with whole exome data; #, individuals analysed for genome-wide CNVs through the CytoScan HD array; blue squares, individuals included in CNV qPCR validation and genotyping analysis, for which heterozygous deletion carriers are indicated as “+/del” and non-carriers are indicated as “+/+”. Inferred genotypes are in parentheses. C) Gene dosage results of the qPCR experiments validating the deletion in patient 8401, and showing the deletion in unaffected subject 8407.</p>
</caption>
<graphic xlink:href="pgen.1007535.g002"></graphic>
</fig>
</sec>
</sec>
<sec id="sec009" sec-type="conclusions">
<title>Discussion</title>
<p>During the last decade, the <italic>CNTNAP2</italic> gene has received considerable attention in the psychiatric genetics field, with a number of studies examining gene dosage, and common or rare variants associations across multiple major psychiatric disorders, which together provided compelling evidence that <italic>CNTNAP2</italic> may be a risk gene with pleiotropic effects in psychiatry. While homozygous mutations in this gene lead to a rare and severe condition described as CASPR2 deficiency disorder (CDD) [<xref ref-type="bibr" rid="pgen.1007535.ref007">7</xref>], characterized by profound intellectual disability, epilepsy, language impairment or regression [<xref ref-type="bibr" rid="pgen.1007535.ref007">7</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref008">8</xref>], heterozygous mutations or common variants have been suggested to be implicated in autism, whose clinical features overlap with some observed in CDD. <italic>CNTNAP2</italic> is categorised in the SFARI database as syndromic gene and one of the highest-ranking “strong candidate” gene for ASD (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/">https://gene.sfari.org</ext-link>). Heterozygous deletions encompassing the <italic>CNTNAP2</italic> gene were described not only in autism but a wide range of phenotypes, including psychiatric or neurologic disorders, and language-related deficiencies. These structural variants were generally described as causative or highly penetrant [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref029">29</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref031">31</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref055">55</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref057">57</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref059">59</xref>].</p>
<p>Examination of the distribution of all structural variants described thus far in psychiatric or neurologic patients showed comparable localisation to those found in the general population, suggesting that structural variants affecting <italic>CNTNAP2</italic> may be less relevant in disease susceptibility than previously considered. We were not able to directly compare frequencies of observed structural variants in cases versus controls due to reporting bias in case reports and a lack of information on how many cases were screened to identify those subjects with reportable <italic>CNTNAP2</italic> CNVs, which is a limitation of this study. In the ExAC database, <italic>CNTNAP2</italic> had fewer CNV variants than expected (11 observed vs. 16 expected, z = 0.43; <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org</ext-link>), and its haploinsufficiency score of 0.59 is in the 8<sup>th</sup> decile of all genes [<xref ref-type="bibr" rid="pgen.1007535.ref079">79</xref>], suggesting that <italic>CNTNAP2</italic> has a tendency to be intolerant to structural variants. A specific case-control CNV analysis is needed to examine CNV frequency differences, but would require a very large sample due to the rarity of CNVs at this locus. A close clinical psychiatric examination of the 66 parents with heterozygous deletions across <italic>CNTNAP2</italic> of CDD provides information on the prevalence of psychiatric conditions in individuals carrying <italic>CNTNAP2</italic> CNVs. All heterozygous family members carrying deletions or truncating mutations were described as phenotypically healthy, suggesting a lack of correlation between these deletions and any major psychiatric condition. Furthermore, parents who were carriers for heterozygous deletions in psychiatric/neurologic patients were described as unaffected at the time of reporting [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref029">29</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref031">31</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref037">37</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref054">54</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref062">62</xref>], with two exception: one father of a proband with neonatal convulsion, and another father of an epileptic patient, were reported as affected [<xref ref-type="bibr" rid="pgen.1007535.ref056">56</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref059">59</xref>]. Moreover, discordant segregation for deletions in <italic>CNTNAP2</italic> was also observed in an ASD sib-pair [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>]. Several psychiatric patients who were reported to carry heterozygous structural variants in <italic>CNTNAP2</italic> were also described with translocations or other chromosomal abnormalities [<xref ref-type="bibr" rid="pgen.1007535.ref029">29</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref030">30</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref033">33</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref034">34</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref056">56</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref058">58</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref062">62</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref065">65</xref>], therefore it is possible that these aberrations may explain the phenotype independently from the observed CNVs in <italic>CNTNAP2</italic>.</p>
<p>We also describe a new CNV deletion which does not segregate with disease in an extended family with bipolar disorder. This CNV removes the FOXP2 transcription factor binding site in intron 1 of <italic>CNTNAP2</italic>, and overlaps with structural variants described in a number of other psychiatric patients. This heterozygous deletion was identified in two individuals with bipolar I disorder from an extended family with five affected members, but was observed also in one unaffected relative (who underwent diagnostic interview at age &gt;40 and therefore was beyond the typical age of symptom onset). Hence, the deletion was not segregating with the disease and is unlikely to represent a highly penetrant risk variant in this family, although we cannot exclude a multiple hit model where the CNV deletion interacts with other etiologic risk variants at other loci to exert phenotypic effect.</p>
<p><italic>CNTNAP2</italic><sup><italic>-/-</italic></sup> knock-out mice have been proposed as valid animal model for ASD considering the phenotypic similarities between ASD and the CASPR2 deficiency disorder [<xref ref-type="bibr" rid="pgen.1007535.ref002">2</xref>]. <italic>CNTNAP2</italic><sup><italic>-/-</italic></sup> knock-out mice showed abnormalities in the arborisation of dendrites, maturation of dendritic spines, defects in migration of cortical projection neurons, and reduction of GABAergic interneurons [<xref ref-type="bibr" rid="pgen.1007535.ref002">2</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref004">4</xref>]. Controversially, ASD is not a core feature in the most recent patient series reported with CASPR2 deficiency disorder [<xref ref-type="bibr" rid="pgen.1007535.ref007">7</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref008">8</xref>]. The association previously proposed around the relationship between heterozygous deletions in <italic>CNTNAP2</italic> and ASD does not have a support from mouse models, as heterozygous mice did not show any behavioural or neuropathological abnormalities that were observed in homozygous knockouts [<xref ref-type="bibr" rid="pgen.1007535.ref002">2</xref>]. Notwithstanding this, it is possible that the combination of heterozygous <italic>CNTNAP2</italic> deletions in a genomic background of increased risk (through inheritance of other common and rare risk variants at other loci) may lead to psychiatric, behavioural or neuropathological abnormalities.</p>
<p>Common variants in <italic>CNTNAP2</italic> are another class of genetic variation associated with several psychiatric or language-related phenotypes. The most interesting finding from studies of this variant class converge on markers rs7794745 and rs2710102, originally reported in ASD [<xref ref-type="bibr" rid="pgen.1007535.ref013">13</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref014">14</xref>], and replicated later in ASD or implicated in other phenotypes [<xref ref-type="bibr" rid="pgen.1007535.ref012">12</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref023">23</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref024">24</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref046">46</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref048">48</xref>]. Neuroimaging studies have supported the notion that these common variants play a role in psychiatric disorders. SNP rs2710102 has been implicated in brain connectivity in healthy individuals [<xref ref-type="bibr" rid="pgen.1007535.ref016">16</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref018">18</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref019">19</xref>], and rs7794745 was implicated in audio-visual speech perception [<xref ref-type="bibr" rid="pgen.1007535.ref080">80</xref>], voice-specific brain function [<xref ref-type="bibr" rid="pgen.1007535.ref022">22</xref>], and was associated with reduced grey matter volume in left superior occipital gyrus [<xref ref-type="bibr" rid="pgen.1007535.ref020">20</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref021">21</xref>]. These studies focused principally on language tasks in general population, given the reported suggestive implications of <italic>CNTNAP2</italic> in language impairment traits of ASD or language-related phenotypes. However, the direct role of <italic>CNTNAP2</italic> in language is still unclear; indeed the language regression observed in patients with CASPR2 deficiency disorder are concomitant with seizure onset and may represent a secondary phenotypic effect caused by seizures [<xref ref-type="bibr" rid="pgen.1007535.ref007">7</xref>]. On the other hand, the first genetic association of rs7794745 and rs2710102 with ASD, as well as the other psychiatric diseases were based in studies with limited sample size, and recent studies failed to replicate associations between the two markers and ASD [<xref ref-type="bibr" rid="pgen.1007535.ref081">81</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref082">82</xref>]. Individual alleles associated in the past with limited numbers of patients warrant replications in adequately powered samples to ascertain <italic>bona fide</italic> findings considering the small size effects of common variants [<xref ref-type="bibr" rid="pgen.1007535.ref083">83</xref>], such as that attempted here. Using the largest case-control cohorts currently publicly available (PGC datasets), we did not find evidence for significant association of previously reported common variants, or a combined effect for common variants of <italic>CNTNAP2</italic> in the susceptibility of psychiatric disorders, nor did we find predicted functional SNPs with a role across disorders.</p>
<p>Finally, we examine evidence for rare variant contributions in <italic>CNTNAP2</italic>. Rare variants in the promoter or coding region were reported to play a role in the pathophysiology of ASD [<xref ref-type="bibr" rid="pgen.1007535.ref025">25</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref033">33</xref>], although a recent study including a large number of cases and controls did not find association of rare variants of <italic>CNTNAP2</italic> in ASD [<xref ref-type="bibr" rid="pgen.1007535.ref084">84</xref>]. Here we report the largest sample investigated thus far in ASD and schizophrenia, which suggests that rare variants in <italic>CNTNAP2</italic> do not play a major role in these two psychiatric disorders. Furthermore, examination of <italic>de novo</italic> variants in combined psychiatric sequencing projects of over 15,500 trios suggest that <italic>de novo</italic> variants in <italic>CNTNAP2</italic> do not increase risk for psychiatric disorders.</p>
<p>While functional studies show a relationship between certain deletions or rare variants of <italic>CNTNAP2</italic> with neuronal phenotypes relevant to psychiatric illness [<xref ref-type="bibr" rid="pgen.1007535.ref025">25</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref054">54</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref085">85</xref>], we show that the genetic link between these variants and psychiatric phenotypes is tenuous. However, this does not dispel the evidence that the <italic>CNTNAP2</italic> gene, or specific genetic variations within this gene, may have a real impact on neuronal functions or variability of brain connectivity in the general population.</p>
<p>It is now possible to combine large datasets to ascertain the real impact of candidate genes described in the past in psychiatric disorders. Here we performed analyses using large publicly available datasets investigating a range of mutational mechanisms which impact variability of <italic>CNTNAP2</italic> across several psychiatric disorders. In conclusion, our results converge to show a limited or likely neutral role of <italic>CNTNAP2</italic> in the susceptibility of psychiatric disorders. However, the impact of this gene in language deficit <italic>per se</italic> is not directly examined in this study and warrants additional investigation.</p>
</sec>
<sec id="sec010" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec011">
<title>Common variant association in <italic>CNTNAP2</italic> using publicly available datasets</title>
<p>We sought to replicate previously reported <italic>CNTNAP2</italic> SNP associations in a range of psychiatric phenotypes or traits using GWAS summary-statistic data of the Psychiatric Genomics Consortium (<ext-link ext-link-type="uri" xlink:href="https://med.unc.edu/pgc/results-and-downloads">https://med.unc.edu/pgc/results-and-downloads</ext-link>).</p>
<p>Firstly, we report the corresponding <italic>P-value</italic>s of specific previously associated markers for case-control cohorts with autism spectrum disorder (ASD), schizophrenia (SCZ), bipolar disorder (BD), attention-deficit hyperactivity-disorder (ADHD), major depressive disorder (MDD), anorexia nervosa (AN), and obsessive compulsive disorder (OCD). If a specific SNP marker was not reported in an individual GWAS dataset, we selected another marker in high linkage disequilibrium (r<sup>2</sup>~1, using genotype data from the CEU, TSI, GBR and IBS European populations in 1000genomes project; <ext-link ext-link-type="uri" xlink:href="http://www.internationalgenome.org/">http://www.internationalgenome.org</ext-link>).</p>
<p>Next, a gene-based association for common variants was calculated with MAGMA [<xref ref-type="bibr" rid="pgen.1007535.ref086">86</xref>], using variants within a 5 kb window upstream and downstream of <italic>CNTNAP2</italic>. Selected datasets were of European descent, derived from GWAS summary statistics of the Psychiatric Genomics Consortium (<ext-link ext-link-type="uri" xlink:href="https://med.unc.edu/pgc/results-and-downloads">https://med.unc.edu/pgc/results-and-downloads</ext-link>): SCZ (33,640 cases and 43,456 controls), BD (20,352 cases and 31,358 controls), ASD (6,197 and 7,377 controls), ADHD (19,099 cases and 34,194 controls), MDD (9,240 cases and 9,519 controls), OCD (2,688 cases and 7,037 controls), and AN (3,495 cases and 10,982 controls) [<xref ref-type="bibr" rid="pgen.1007535.ref087">87</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref093">93</xref>]. Analyses were performed combining two different models for higher statistical power and sensitivity when the genetic architecture is unknown: the combined <italic>P-value</italic> model, which is more sensitive when only a small proportion of key SNPs in a gene show association; and the mean SNP association, which is more sensitive when allelic heterogeneity is greater and a larger number of SNPs show nominal association.</p>
<p>Finally, we selected SNPs predicted to be functional within a 5kb window upstream/downstream of <italic>CNTNAP2</italic> (e.g. located in transcription factor binding sites, miRNA binding sites etc; <ext-link ext-link-type="uri" xlink:href="https://snpinfo.niehs.nih.gov/">https://snpinfo.niehs.nih.gov</ext-link>), and assessed a potential cross-disorder effect using GWAS summary statistics data of the PGC by performing a meta-analysis in PLINK [<xref ref-type="bibr" rid="pgen.1007535.ref094">94</xref>]. The Cochran’s Q-statistic and I<sup>2</sup> statistic were calculated to examine heterogeneity amongst studies. The null hypothesis was that all studies were measuring the same true effect, which would be rejected if heterogeneity exists across studies. For all functional SNPs, when heterogeneity between studies was I&gt;50% (<italic>P</italic>&lt;0.05), the pooled OR was estimated using a random-effects model.</p>
</sec>
<sec id="sec012">
<title>Analysis of rare variants in <italic>CNTNAP2</italic> in ASD and schizophrenia, and <italic>de novo</italic> variants across psychiatric cohorts</title>
<p>The impact of rare variants of <italic>CNTNAP2</italic> was assessed using sequencing-level data from the following datasets: WES from the Sweden-Schizophrenia population-based Case-Control cohort (6,135 cases and 6,245 controls; dbGAP accession: phs000473.v2.p2); ARRA Autism Sequencing Collaboration (490 BCM cases, BCM 486 controls, and 1,288 unrelated ASD probands from consent code c1; dbGAP accession: phs000298.v3.p2); Medical Genome Reference Bank (2,845 healthy Australian adults; <ext-link ext-link-type="uri" xlink:href="https://sgc.garvan.org.au/initiatives/mgrb">https://sgc.garvan.org.au/initiatives/mgrb</ext-link>); individuals from a Caucasian Spanish population (719 controls [<xref ref-type="bibr" rid="pgen.1007535.ref095">95</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref096">96</xref>]); in-house ASD patients (30 cases; [<xref ref-type="bibr" rid="pgen.1007535.ref097">97</xref>]); and previous published dataset in ASD (2,704 cases and 2,747 controls [<xref ref-type="bibr" rid="pgen.1007535.ref084">84</xref>]). The selection of potentially etiologic variants was performed based on their predicted pathogenicity (missense damaging in both SIFT and polyphen 2, canonical splice variants, stop mutation and indels) and minor allele frequency (MAF&lt;0.0001 in non-Finnish European populations using the Genome Aggregation Database; <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</ext-link>). A chi square statistic was used to compare separately the sample of schizophrenia patients (6,135 cases) and the combined ASD datasets (4,512 cases) with the combined control datasets (13,042 individuals).</p>
<p>Two databases for <italic>de novo</italic> variants were used to identify <italic>de novo</italic> variants in <italic>CNTNAP2</italic> [<xref ref-type="bibr" rid="pgen.1007535.ref098">98</xref>, <xref ref-type="bibr" rid="pgen.1007535.ref099">99</xref>], which comprise data for the following samples: autism spectrum disorder (6,171 families), schizophrenia (1,164 families), epilepsy (647 families), intellectual disability (1,101 families), developmental disorders (4,293 families) and controls (2,163).</p>
</sec>
<sec id="sec013">
<title>Extended family with bipolar disorder and CNV in <italic>CNTNAP2</italic></title>
<p>The extended family presented here (<xref ref-type="fig" rid="pgen.1007535.g002">Fig 2B</xref>) provides a molecular follow-up from a previously reported whole exome sequencing (WES) study of multiplex BD families, augmented with CNV microarray data [<xref ref-type="bibr" rid="pgen.1007535.ref078">78</xref>]. This multigenerational pedigree, was collected through the Mood Disorders Unit and Black Dog Institute at the Prince of Wales Hospital, Sydney, and the School of Psychiatry (University of New South Wales in Sydney) [<xref ref-type="bibr" rid="pgen.1007535.ref100">100</xref>–<xref ref-type="bibr" rid="pgen.1007535.ref104">104</xref>]. Consenting family members were assessed using the Family Interview for Genetic Studies (FIGS) [<xref ref-type="bibr" rid="pgen.1007535.ref105">105</xref>], and the Diagnostic Interview for Genetic Studies (DIGS) [<xref ref-type="bibr" rid="pgen.1007535.ref106">106</xref>]. The study was approved by the Human Research Ethics Committee of the University of New South Wales, and written informed consent was obtained from all participating individuals. Blood samples were collected for DNA extraction by standard laboratory methods. Three of the five relatives with bipolar disorder type I (BD-I) had DNA and WES-derived genotype data available, and six unaffected relatives with DNA and WES data were available for haplotype phasing and segregation analysis (<xref ref-type="fig" rid="pgen.1007535.g002">Fig 2B</xref>).</p>
<p>Genome-wide CNV analysis was performed via CytoScan HD Array (Affymetrix, Santa Clara, CA, USA) in 2 distal affected relatives (individuals 8410 and 8401; <xref ref-type="fig" rid="pgen.1007535.g002">Fig 2B</xref>), using the Affymetrix Chromosome Analysis Suite (ChAS) software (ThermoFisher, Waltham, MA, USA). Detailed information on CNV detection and filtering criteria have been previously described [<xref ref-type="bibr" rid="pgen.1007535.ref078">78</xref>]. We identified a 131kb deletion in intron 1 of <italic>CNTNAP2</italic> in individual 8401. WES-derived genotypes were used for haplotype assessment to infer CNV segregation amongst relatives, as previously described [<xref ref-type="bibr" rid="pgen.1007535.ref078">78</xref>]. Next, we experimentally validated the <italic>CNTNAP2</italic> CNV via quantitative PCR (qPCR) in all available family members. Validation was performed in quadruplicate via a SYBR Green-based quantitative PCR (qPCR) method using two independent amplicon probes, each compared with two different reference amplicon probes in the <italic>FOXP2</italic> and <italic>RNF20</italic> genes (<xref ref-type="supplementary-material" rid="pgen.1007535.s006">S4 Table</xref>). Experimental details are available upon request.</p>
</sec>
</sec>
<sec id="sec014" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="pgen.1007535.s001">
<label>S1 Fig</label>
<caption>
<title>CNTNAP association plots using GWAS summary statistics of the PGC data sets.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pgen.1007535.s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1007535.s002">
<label>S2 Fig</label>
<caption>
<title>Cross-disorder association plot of <italic>CNTNAP2</italic> common variants predicted to be functional (63 SNPs).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pgen.1007535.s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1007535.s003">
<label>S1 Table</label>
<caption>
<title>Gene-based analysis of predicted functional SNPs across seven psychiatric disorders.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pgen.1007535.s003.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1007535.s004">
<label>S2 Table</label>
<caption>
<title>Full list of d<italic>e novo</italic> variants in <italic>CNTNAP2</italic> gene.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pgen.1007535.s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1007535.s005">
<label>S3 Table</label>
<caption>
<title>Full list of Ultra-Rare Variants (URVs) in available sequencing datasets.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pgen.1007535.s005.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pgen.1007535.s006">
<label>S4 Table</label>
<caption>
<title>Primers used in the CNV validation for the <italic>CNTNAP2</italic> intronic deletion.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pgen.1007535.s006.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Xose S. Puente from the University of Oviedo (Spain) for providing us the data from a Spanish control population. We are grateful to all participants and their families, as well as clinical collaborators who were originally involved in collecting and phenotyping these families, including Laila Tabassum, and Adam Wright (UNSW).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pgen.1007535.ref001">
<label>1</label>
<mixed-citation publication-type="journal"><name><surname>Poliak</surname><given-names>S</given-names></name>, <name><surname>Salomon</surname><given-names>D</given-names></name>, <name><surname>Elhanany</surname><given-names>H</given-names></name>, <name><surname>Sabanay</surname><given-names>H</given-names></name>, <name><surname>Kiernan</surname><given-names>B</given-names></name>, <name><surname>Pevny</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1</article-title>. <source/>The Journal of cell biology. <year>2003</year>;<volume>162</volume>(<issue>6</issue>):<fpage>1149</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200305018</pub-id>
<pub-id pub-id-type="pmid">12963709</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Penagarikano</surname><given-names>O</given-names></name>, <name><surname>Abrahams</surname><given-names>BS</given-names></name>, <name><surname>Herman</surname><given-names>EI</given-names></name>, <name><surname>Winden</surname><given-names>KD</given-names></name>, <name><surname>Gdalyahu</surname><given-names>A</given-names></name>, <name><surname>Dong</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits</article-title>. <source/>Cell. <year>2011</year>;<volume>147</volume>(<issue>1</issue>):<fpage>235</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.040</pub-id>
<pub-id pub-id-type="pmid">21962519</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Abrahams</surname><given-names>BS</given-names></name>, <name><surname>Tentler</surname><given-names>D</given-names></name>, <name><surname>Perederiy</surname><given-names>JV</given-names></name>, <name><surname>Oldham</surname><given-names>MC</given-names></name>, <name><surname>Coppola</surname><given-names>G</given-names></name>, <name><surname>Geschwind</surname><given-names>DH</given-names></name>. <article-title>Genome-wide analyses of human perisylvian cerebral cortical patterning</article-title>. <source/>Proceedings of the National Academy of Sciences of the United States of America. <year>2007</year>;<volume>104</volume>(<issue>45</issue>):<fpage>17849</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706128104</pub-id>
<pub-id pub-id-type="pmid">17978184</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref004">
<label>4</label>
<mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>GR</given-names></name>, <name><surname>Galfin</surname><given-names>T</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <name><surname>Aoto</surname><given-names>J</given-names></name>, <name><surname>Malenka</surname><given-names>RC</given-names></name>, <name><surname>Sudhof</surname><given-names>TC</given-names></name>. <article-title>Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development</article-title>. <source/>Proceedings of the National Academy of Sciences of the United States of America. <year>2012</year>;<volume>109</volume>(<issue>44</issue>):<fpage>18120</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1216398109</pub-id>
<pub-id pub-id-type="pmid">23074245</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Strauss</surname><given-names>KA</given-names></name>, <name><surname>Puffenberger</surname><given-names>EG</given-names></name>, <name><surname>Huentelman</surname><given-names>MJ</given-names></name>, <name><surname>Gottlieb</surname><given-names>S</given-names></name>, <name><surname>Dobrin</surname><given-names>SE</given-names></name>, <name><surname>Parod</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2</article-title>. <source/>The New England journal of medicine. <year>2006</year>;<volume>354</volume>(<issue>13</issue>):<fpage>1370</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa052773</pub-id> .<pub-id pub-id-type="pmid">16571880</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Zweier</surname><given-names>C</given-names></name>, <name><surname>de Jong</surname><given-names>EK</given-names></name>, <name><surname>Zweier</surname><given-names>M</given-names></name>, <name><surname>Orrico</surname><given-names>A</given-names></name>, <name><surname>Ousager</surname><given-names>LB</given-names></name>, <name><surname>Collins</surname><given-names>AL</given-names></name>, <etal>et al</etal>
<article-title>CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila</article-title>. <source/>American journal of human genetics. <year>2009</year>;<volume>85</volume>(<issue>5</issue>):<fpage>655</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2009.10.004</pub-id>
<pub-id pub-id-type="pmid">19896112</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Rodenas-Cuadrado</surname><given-names>P</given-names></name>, <name><surname>Pietrafusa</surname><given-names>N</given-names></name>, <name><surname>Francavilla</surname><given-names>T</given-names></name>, <name><surname>La Neve</surname><given-names>A</given-names></name>, <name><surname>Striano</surname><given-names>P</given-names></name>, <name><surname>Vernes</surname><given-names>SC</given-names></name>. <article-title>Characterisation of CASPR2 deficiency disorder—a syndrome involving autism, epilepsy and language impairment</article-title>. <source/>BMC medical genetics. <year>2016</year>;<volume>17</volume>:<fpage>8</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-016-0272-8</pub-id>
<pub-id pub-id-type="pmid">26843181</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Smogavec</surname><given-names>M</given-names></name>, <name><surname>Cleall</surname><given-names>A</given-names></name>, <name><surname>Hoyer</surname><given-names>J</given-names></name>, <name><surname>Lederer</surname><given-names>D</given-names></name>, <name><surname>Nassogne</surname><given-names>MC</given-names></name>, <name><surname>Palmer</surname><given-names>EE</given-names></name>, <etal>et al</etal>
<article-title>Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum</article-title>. <source/>Journal of medical genetics. <year>2016</year>;<volume>53</volume>(<issue>12</issue>):<fpage>820</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2016-103880</pub-id> .<pub-id pub-id-type="pmid">27439707</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Watson</surname><given-names>CM</given-names></name>, <name><surname>Crinnion</surname><given-names>LA</given-names></name>, <name><surname>Tzika</surname><given-names>A</given-names></name>, <name><surname>Mills</surname><given-names>A</given-names></name>, <name><surname>Coates</surname><given-names>A</given-names></name>, <name><surname>Pendlebury</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Diagnostic whole genome sequencing and split-read mapping for nucleotide resolution breakpoint identification in CNTNAP2 deficiency syndrome</article-title>. <source/>American journal of medical genetics Part A. <year>2014</year>;<volume>164A</volume>(<issue>10</issue>):<fpage>2649</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36679</pub-id> .<pub-id pub-id-type="pmid">25045150</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref010">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>Kale</surname><given-names>T</given-names></name>, <name><surname>Philip</surname><given-names>M</given-names></name>. <article-title>An Interstitial Deletion at 7q33-36.1 in a Patient with Intellectual Disability, Significant Language Delay, and</article-title>
<source/>Severe Microcephaly. Case reports in genetics. <year>2016</year>;<volume>2016</volume>:<fpage>6046351</fpage>
<pub-id pub-id-type="doi">10.1155/2016/6046351</pub-id>
<pub-id pub-id-type="pmid">28053794</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Lai</surname><given-names>CS</given-names></name>, <name><surname>Fisher</surname><given-names>SE</given-names></name>, <name><surname>Hurst</surname><given-names>JA</given-names></name>, <name><surname>Vargha-Khadem</surname><given-names>F</given-names></name>, <name><surname>Monaco</surname><given-names>AP</given-names></name>. <article-title>A forkhead-domain gene is mutated in a severe speech and language disorder</article-title>. <source/>Nature. <year>2001</year>;<volume>413</volume>(<issue>6855</issue>):<fpage>519</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/35097076</pub-id> .<pub-id pub-id-type="pmid">11586359</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Vernes</surname><given-names>SC</given-names></name>, <name><surname>Newbury</surname><given-names>DF</given-names></name>, <name><surname>Abrahams</surname><given-names>BS</given-names></name>, <name><surname>Winchester</surname><given-names>L</given-names></name>, <name><surname>Nicod</surname><given-names>J</given-names></name>, <name><surname>Groszer</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>A functional genetic link between distinct developmental language disorders</article-title>. <source/>The New England journal of medicine. <year>2008</year>;<volume>359</volume>(<issue>22</issue>):<fpage>2337</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0802828</pub-id>
<pub-id pub-id-type="pmid">18987363</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Alarcon</surname><given-names>M</given-names></name>, <name><surname>Abrahams</surname><given-names>BS</given-names></name>, <name><surname>Stone</surname><given-names>JL</given-names></name>, <name><surname>Duvall</surname><given-names>JA</given-names></name>, <name><surname>Perederiy</surname><given-names>JV</given-names></name>, <name><surname>Bomar</surname><given-names>JM</given-names></name>, <etal>et al</etal>
<article-title>Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene</article-title>. <source/>American journal of human genetics. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>150</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.005</pub-id>
<pub-id pub-id-type="pmid">18179893</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Arking</surname><given-names>DE</given-names></name>, <name><surname>Cutler</surname><given-names>DJ</given-names></name>, <name><surname>Brune</surname><given-names>CW</given-names></name>, <name><surname>Teslovich</surname><given-names>TM</given-names></name>, <name><surname>West</surname><given-names>K</given-names></name>, <name><surname>Ikeda</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism</article-title>. <source/>American journal of human genetics. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>160</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.015</pub-id>
<pub-id pub-id-type="pmid">18179894</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Whitehouse</surname><given-names>AJ</given-names></name>, <name><surname>Bishop</surname><given-names>DV</given-names></name>, <name><surname>Ang</surname><given-names>QW</given-names></name>, <name><surname>Pennell</surname><given-names>CE</given-names></name>, <name><surname>Fisher</surname><given-names>SE</given-names></name>. <article-title>CNTNAP2 variants affect early language development in the general population</article-title>. <source/>Genes, brain, and behavior. <year>2011</year>;<volume>10</volume>(<issue>4</issue>):<fpage>451</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00684.x</pub-id>
<pub-id pub-id-type="pmid">21310003</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Whalley</surname><given-names>HC</given-names></name>, <name><surname>O'Connell</surname><given-names>G</given-names></name>, <name><surname>Sussmann</surname><given-names>JE</given-names></name>, <name><surname>Peel</surname><given-names>A</given-names></name>, <name><surname>Stanfield</surname><given-names>AC</given-names></name>, <name><surname>Hayiou-Thomas</surname><given-names>ME</given-names></name>, <etal>et al</etal>
<article-title>Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals</article-title>. <source/>American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. <year>2011</year>;<volume>156B</volume>(<issue>8</issue>):<fpage>941</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.31241</pub-id> .<pub-id pub-id-type="pmid">21987501</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Clemm von Hohenberg</surname><given-names>C</given-names></name>, <name><surname>Wigand</surname><given-names>MC</given-names></name>, <name><surname>Kubicki</surname><given-names>M</given-names></name>, <name><surname>Leicht</surname><given-names>G</given-names></name>, <name><surname>Giegling</surname><given-names>I</given-names></name>, <name><surname>Karch</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study</article-title>. <source/>Journal of psychiatric research. <year>2013</year>;<volume>47</volume>(<issue>10</issue>):<fpage>1349</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.07.002</pub-id>
<pub-id pub-id-type="pmid">23871450</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Scott-Van Zeeland</surname><given-names>AA</given-names></name>, <name><surname>Abrahams</surname><given-names>BS</given-names></name>, <name><surname>Alvarez-Retuerto</surname><given-names>AI</given-names></name>, <name><surname>Sonnenblick</surname><given-names>LI</given-names></name>, <name><surname>Rudie</surname><given-names>JD</given-names></name>, <name><surname>Ghahremani</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2</article-title>. <source/>Science translational medicine. <year>2010</year>;<volume>2</volume>(<issue>56</issue>):<fpage>56ra80</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3001344</pub-id>
<pub-id pub-id-type="pmid">21048216</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Dennis</surname><given-names>EL</given-names></name>, <name><surname>Jahanshad</surname><given-names>N</given-names></name>, <name><surname>Rudie</surname><given-names>JD</given-names></name>, <name><surname>Brown</surname><given-names>JA</given-names></name>, <name><surname>Johnson</surname><given-names>K</given-names></name>, <name><surname>McMahon</surname><given-names>KL</given-names></name>, <etal>et al</etal>
<article-title>Altered structural brain connectivity in healthy carriers of the autism risk gene, CNTNAP2</article-title>. <source/>Brain Connect. <year>2011</year>;<volume>1</volume>(<issue>6</issue>):<fpage>447</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1089/brain.2011.0064</pub-id>
<pub-id pub-id-type="pmid">22500773</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>GC</given-names></name>, <name><surname>Doke</surname><given-names>TF</given-names></name>, <name><surname>Ashburner</surname><given-names>J</given-names></name>, <name><surname>Wood</surname><given-names>NW</given-names></name>, <name><surname>Frackowiak</surname><given-names>RS</given-names></name>. <article-title>Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2</article-title>. <source/>NeuroImage. <year>2010</year>;<volume>53</volume>(<issue>3</issue>):<fpage>1030</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.02.018</pub-id>
<pub-id pub-id-type="pmid">20176116</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Udden</surname><given-names>J</given-names></name>, <name><surname>Snijders</surname><given-names>TM</given-names></name>, <name><surname>Fisher</surname><given-names>SE</given-names></name>, <name><surname>Hagoort</surname><given-names>P</given-names></name>. <article-title>A common variant of the CNTNAP2 gene is associated with structural variation in the left superior occipital gyrus</article-title>. <source/>Brain and language. <year>2017</year>;<volume>172</volume>:<fpage>16</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.bandl.2016.02.003</pub-id> .<pub-id pub-id-type="pmid">27059522</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref022">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Koeda</surname><given-names>M</given-names></name>, <name><surname>Watanabe</surname><given-names>A</given-names></name>, <name><surname>Tsuda</surname><given-names>K</given-names></name>, <name><surname>Matsumoto</surname><given-names>M</given-names></name>, <name><surname>Ikeda</surname><given-names>Y</given-names></name>, <name><surname>Kim</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Interaction effect between handedness and CNTNAP2 polymorphism (rs7794745 genotype) on voice-specific frontotemporal activity in healthy individuals: an fMRI study</article-title>. <source/>Frontiers in behavioral neuroscience. <year>2015</year>;<volume>9</volume>:<fpage>87</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2015.00087</pub-id>
<pub-id pub-id-type="pmid">25941478</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Steer</surname><given-names>CD</given-names></name>, <name><surname>Golding</surname><given-names>J</given-names></name>, <name><surname>Bolton</surname><given-names>PF</given-names></name>. <article-title>Traits contributing to the autistic spectrum</article-title>. <source/>PloS one. <year>2010</year>;<volume>5</volume>(<issue>9</issue>):<fpage>e12633</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0012633</pub-id>
<pub-id pub-id-type="pmid">20838614</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Nascimento</surname><given-names>PP</given-names></name>, <name><surname>Bossolani-Martins</surname><given-names>AL</given-names></name>, <name><surname>Rosan</surname><given-names>DB</given-names></name>, <name><surname>Mattos</surname><given-names>LC</given-names></name>, <name><surname>Brandao-Mattos</surname><given-names>C</given-names></name>, <name><surname>Fett-Conte</surname><given-names>AC</given-names></name>. <article-title>Single nucleotide polymorphisms in the CNTNAP2 gene in Brazilian patients with autistic spectrum disorder</article-title>. <source/>Genetics and molecular research: GMR. <year>2016</year>;<volume>15</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.4238/gmr.15017422</pub-id> .<pub-id pub-id-type="pmid">26909962</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Chiocchetti</surname><given-names>AG</given-names></name>, <name><surname>Kopp</surname><given-names>M</given-names></name>, <name><surname>Waltes</surname><given-names>R</given-names></name>, <name><surname>Haslinger</surname><given-names>D</given-names></name>, <name><surname>Duketis</surname><given-names>E</given-names></name>, <name><surname>Jarczok</surname><given-names>TA</given-names></name>, <etal>et al</etal>
<article-title>Variants of the CNTNAP2 5' promoter as risk factors for autism spectrum disorders: a genetic and functional approach</article-title>. <source/>Molecular psychiatry. <year>2015</year>;<volume>20</volume>(<issue>7</issue>):<fpage>839</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.103</pub-id> .<pub-id pub-id-type="pmid">25224256</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref026">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Sampath</surname><given-names>S</given-names></name>, <name><surname>Bhat</surname><given-names>S</given-names></name>, <name><surname>Gupta</surname><given-names>S</given-names></name>, <name><surname>O'Connor</surname><given-names>A</given-names></name>, <name><surname>West</surname><given-names>AB</given-names></name>, <name><surname>Arking</surname><given-names>DE</given-names></name>, <etal>et al</etal>
<article-title>Defining the contribution of CNTNAP2 to autism susceptibility</article-title>. <source/>PloS one. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e77906</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0077906</pub-id>
<pub-id pub-id-type="pmid">24147096</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref027">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Anney</surname><given-names>R</given-names></name>, <name><surname>Klei</surname><given-names>L</given-names></name>, <name><surname>Pinto</surname><given-names>D</given-names></name>, <name><surname>Almeida</surname><given-names>J</given-names></name>, <name><surname>Bacchelli</surname><given-names>E</given-names></name>, <name><surname>Baird</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Individual common variants exert weak effects on the risk for autism spectrum disorders</article-title>. <source/>Human molecular genetics. <year>2012</year>;<volume>21</volume>(<issue>21</issue>):<fpage>4781</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds301</pub-id>
<pub-id pub-id-type="pmid">22843504</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Poot</surname><given-names>M.</given-names></name>
<article-title>A candidate gene association study further corroborates involvement of contactin genes in autism</article-title>. <source/>Molecular syndromology. <year>2014</year>;<volume>5</volume>(<issue>5</issue>):<fpage>229</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1159/000362891</pub-id>
<pub-id pub-id-type="pmid">25337070</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Gregor</surname><given-names>A</given-names></name>, <name><surname>Albrecht</surname><given-names>B</given-names></name>, <name><surname>Bader</surname><given-names>I</given-names></name>, <name><surname>Bijlsma</surname><given-names>EK</given-names></name>, <name><surname>Ekici</surname><given-names>AB</given-names></name>, <name><surname>Engels</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1</article-title>. <source/>BMC medical genetics. <year>2011</year>;<volume>12</volume>:<fpage>106</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-12-106</pub-id>
<pub-id pub-id-type="pmid">21827697</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Belloso</surname><given-names>JM</given-names></name>, <name><surname>Bache</surname><given-names>I</given-names></name>, <name><surname>Guitart</surname><given-names>M</given-names></name>, <name><surname>Caballin</surname><given-names>MR</given-names></name>, <name><surname>Halgren</surname><given-names>C</given-names></name>, <name><surname>Kirchhoff</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome</article-title>. <source/>European journal of human genetics: EJHG. <year>2007</year>;<volume>15</volume>(<issue>6</issue>):<fpage>711</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201824</pub-id> .<pub-id pub-id-type="pmid">17392702</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref031">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>Polimanti</surname><given-names>R</given-names></name>, <name><surname>Squitti</surname><given-names>R</given-names></name>, <name><surname>Pantaleo</surname><given-names>M</given-names></name>, <name><surname>Giglio</surname><given-names>S</given-names></name>, <name><surname>Zito</surname><given-names>G</given-names></name>. <article-title>Duplication of FOXP2 binding sites within CNTNAP2 gene in a girl with neurodevelopmental delay</article-title>. <source/>Minerva pediatrica. <year>2017</year>;<volume>69</volume>(<issue>2</issue>):<fpage>162</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.23736/S0026-4946.16.04326-7</pub-id> .<pub-id pub-id-type="pmid">27215640</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Mikhail</surname><given-names>FM</given-names></name>, <name><surname>Lose</surname><given-names>EJ</given-names></name>, <name><surname>Robin</surname><given-names>NH</given-names></name>, <name><surname>Descartes</surname><given-names>MD</given-names></name>, <name><surname>Rutledge</surname><given-names>KD</given-names></name>, <name><surname>Rutledge</surname><given-names>SL</given-names></name>, <etal>et al</etal>
<article-title>Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders</article-title>. <source/>American journal of medical genetics Part A. <year>2011</year>;<volume>155A</volume>(<issue>10</issue>):<fpage>2386</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.34177</pub-id> .<pub-id pub-id-type="pmid">22031302</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Bakkaloglu</surname><given-names>B</given-names></name>, <name><surname>O'Roak</surname><given-names>BJ</given-names></name>, <name><surname>Louvi</surname><given-names>A</given-names></name>, <name><surname>Gupta</surname><given-names>AR</given-names></name>, <name><surname>Abelson</surname><given-names>JF</given-names></name>, <name><surname>Morgan</surname><given-names>TM</given-names></name>, <etal>et al</etal>
<article-title>Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders</article-title>. <source/>American journal of human genetics. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>165</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.017</pub-id>
<pub-id pub-id-type="pmid">18179895</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Poot</surname><given-names>M</given-names></name>, <name><surname>Beyer</surname><given-names>V</given-names></name>, <name><surname>Schwaab</surname><given-names>I</given-names></name>, <name><surname>Damatova</surname><given-names>N</given-names></name>, <name><surname>Van't Slot</surname><given-names>R</given-names></name>, <name><surname>Prothero</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder</article-title>. <source/>Neurogenetics. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>81</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-009-0205-1</pub-id> .<pub-id pub-id-type="pmid">19582487</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Girirajan</surname><given-names>S</given-names></name>, <name><surname>Dennis</surname><given-names>MY</given-names></name>, <name><surname>Baker</surname><given-names>C</given-names></name>, <name><surname>Malig</surname><given-names>M</given-names></name>, <name><surname>Coe</surname><given-names>BP</given-names></name>, <name><surname>Campbell</surname><given-names>CD</given-names></name>, <etal>et al</etal>
<article-title>Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder</article-title>. <source/>American journal of human genetics. <year>2013</year>;<volume>92</volume>(<issue>2</issue>):<fpage>221</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.016</pub-id>
<pub-id pub-id-type="pmid">23375656</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Prasad</surname><given-names>A</given-names></name>, <name><surname>Merico</surname><given-names>D</given-names></name>, <name><surname>Thiruvahindrapuram</surname><given-names>B</given-names></name>, <name><surname>Wei</surname><given-names>J</given-names></name>, <name><surname>Lionel</surname><given-names>AC</given-names></name>, <name><surname>Sato</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>A discovery resource of rare copy number variations in individuals with autism spectrum disorder</article-title>. <source/>G3. <year>2012</year>;<volume>2</volume>(<issue>12</issue>):<fpage>1665</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1534/g3.112.004689</pub-id>
<pub-id pub-id-type="pmid">23275889</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Nord</surname><given-names>AS</given-names></name>, <name><surname>Roeb</surname><given-names>W</given-names></name>, <name><surname>Dickel</surname><given-names>DE</given-names></name>, <name><surname>Walsh</surname><given-names>T</given-names></name>, <name><surname>Kusenda</surname><given-names>M</given-names></name>, <name><surname>O'Connor</surname><given-names>KL</given-names></name>, <etal>et al</etal>
<article-title>Reduced transcript expression of genes affected by inherited and de novo CNVs in autism</article-title>. <source/>European journal of human genetics: EJHG. <year>2011</year>;<volume>19</volume>(<issue>6</issue>):<fpage>727</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2011.24</pub-id>
<pub-id pub-id-type="pmid">21448237</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Egger</surname><given-names>G</given-names></name>, <name><surname>Roetzer</surname><given-names>KM</given-names></name>, <name><surname>Noor</surname><given-names>A</given-names></name>, <name><surname>Lionel</surname><given-names>AC</given-names></name>, <name><surname>Mahmood</surname><given-names>H</given-names></name>, <name><surname>Schwarzbraun</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families</article-title>. <source/>Neurogenetics. <year>2014</year>;<volume>15</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-014-0394-0</pub-id> .<pub-id pub-id-type="pmid">24643514</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Vogt</surname><given-names>D</given-names></name>, <name><surname>Cho</surname><given-names>KKA</given-names></name>, <name><surname>Shelton</surname><given-names>SM</given-names></name>, <name><surname>Paul</surname><given-names>A</given-names></name>, <name><surname>Huang</surname><given-names>ZJ</given-names></name>, <name><surname>Sohal</surname><given-names>VS</given-names></name>, <etal>et al</etal>
<article-title>Mouse Cntnap2 and Human CNTNAP2 ASD Alleles Cell Autonomously Regulate PV+ Cortical Interneurons</article-title>. <source/>Cerebral cortex. <year>2017</year>:<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhx248</pub-id> .<pub-id pub-id-type="pmid">28365777</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>Scott</surname><given-names>R</given-names></name>, <name><surname>Sanchez-Aguilera</surname><given-names>A</given-names></name>, <name><surname>van Elst</surname><given-names>K</given-names></name>, <name><surname>Lim</surname><given-names>L</given-names></name>, <name><surname>Dehorter</surname><given-names>N</given-names></name>, <name><surname>Bae</surname><given-names>SE</given-names></name>, <etal>et al</etal>
<article-title>Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior</article-title>. <source/>Cerebral cortex. <year>2017</year>
<pub-id pub-id-type="doi">10.1093/cercor/bhx341</pub-id> .<pub-id pub-id-type="pmid">29300891</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref041">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>KS</given-names></name>, <name><surname>Liu</surname><given-names>XF</given-names></name>, <name><surname>Aragam</surname><given-names>N</given-names></name>. <article-title>A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder</article-title>. <source/>Schizophrenia research. <year>2010</year>;<volume>124</volume>(<issue>1–3</issue>):<fpage>192</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2010.09.002</pub-id> .<pub-id pub-id-type="pmid">20889312</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Zhong</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>. <article-title>Linkage analysis and association analysis in the presence of linkage using age at onset of COGA alcoholism data</article-title>. <source/>BMC genetics. <year>2005</year>;<volume>6</volume>
<issue>Suppl 1</issue>:<fpage>S31</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2156-6-S1-S31</pub-id>
<pub-id pub-id-type="pmid">16451641</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Terracciano</surname><given-names>A</given-names></name>, <name><surname>Sanna</surname><given-names>S</given-names></name>, <name><surname>Uda</surname><given-names>M</given-names></name>, <name><surname>Deiana</surname><given-names>B</given-names></name>, <name><surname>Usala</surname><given-names>G</given-names></name>, <name><surname>Busonero</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association scan for five major dimensions of personality</article-title>. <source/>Molecular psychiatry. <year>2010</year>;<volume>15</volume>(<issue>6</issue>):<fpage>647</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.113</pub-id>
<pub-id pub-id-type="pmid">18957941</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Wray</surname><given-names>NR</given-names></name>, <name><surname>Pergadia</surname><given-names>ML</given-names></name>, <name><surname>Blackwood</surname><given-names>DH</given-names></name>, <name><surname>Penninx</surname><given-names>BW</given-names></name>, <name><surname>Gordon</surname><given-names>SD</given-names></name>, <name><surname>Nyholt</surname><given-names>DR</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned</article-title>. <source/>Molecular psychiatry. <year>2012</year>;<volume>17</volume>(<issue>1</issue>):<fpage>36</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2010.109</pub-id>
<pub-id pub-id-type="pmid">21042317</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref045">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Long</surname><given-names>F</given-names></name>, <name><surname>Cai</surname><given-names>B</given-names></name>, <name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>. <article-title>A novel relationship for schizophrenia, bipolar and major depressive disorder Part 7: A hint from chromosome 7 high density association screen</article-title>. <source/>Behavioural brain research. <year>2015</year>;<volume>293</volume>:<fpage>241</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.06.043</pub-id> .<pub-id pub-id-type="pmid">26192912</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref046">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>Newbury</surname><given-names>DF</given-names></name>, <name><surname>Paracchini</surname><given-names>S</given-names></name>, <name><surname>Scerri</surname><given-names>TS</given-names></name>, <name><surname>Winchester</surname><given-names>L</given-names></name>, <name><surname>Addis</surname><given-names>L</given-names></name>, <name><surname>Richardson</surname><given-names>AJ</given-names></name>, <etal>et al</etal>
<article-title>Investigation of dyslexia and SLI risk variants in reading- and language-impaired subjects</article-title>. <source/>Behavior genetics. <year>2011</year>;<volume>41</volume>(<issue>1</issue>):<fpage>90</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1007/s10519-010-9424-3</pub-id>
<pub-id pub-id-type="pmid">21165691</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref047">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Peter</surname><given-names>B</given-names></name>, <name><surname>Raskind</surname><given-names>WH</given-names></name>, <name><surname>Matsushita</surname><given-names>M</given-names></name>, <name><surname>Lisowski</surname><given-names>M</given-names></name>, <name><surname>Vu</surname><given-names>T</given-names></name>, <name><surname>Berninger</surname><given-names>VW</given-names></name>, <etal>et al</etal>
<article-title>Replication of CNTNAP2 association with nonword repetition and support for FOXP2 association with timed reading and motor activities in a dyslexia family sample</article-title>. <source/>Journal of neurodevelopmental disorders. <year>2011</year>;<volume>3</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/s11689-010-9065-0</pub-id>
<pub-id pub-id-type="pmid">21484596</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref048">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>Stein</surname><given-names>MB</given-names></name>, <name><surname>Yang</surname><given-names>BZ</given-names></name>, <name><surname>Chavira</surname><given-names>DA</given-names></name>, <name><surname>Hitchcock</surname><given-names>CA</given-names></name>, <name><surname>Sung</surname><given-names>SC</given-names></name>, <name><surname>Shipon-Blum</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits</article-title>. <source/>Biological psychiatry. <year>2011</year>;<volume>69</volume>(<issue>9</issue>):<fpage>825</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.11.008</pub-id>
<pub-id pub-id-type="pmid">21193173</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref049">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Pan</surname><given-names>Y</given-names></name>, <name><surname>Tao</surname><given-names>H</given-names></name>, <name><surname>Ju</surname><given-names>K</given-names></name>, <name><surname>Wen</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population</article-title>. <source/>Psychiatry research. <year>2013</year>;<volume>207</volume>(<issue>3</issue>):<fpage>225</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2012.09.024</pub-id> .<pub-id pub-id-type="pmid">23123147</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref050">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>YJ</given-names></name>, <name><surname>Wang</surname><given-names>YP</given-names></name>, <name><surname>Yang</surname><given-names>WZ</given-names></name>, <name><surname>Sun</surname><given-names>HW</given-names></name>, <name><surname>Ma</surname><given-names>HW</given-names></name>, <name><surname>Zhao</surname><given-names>YR</given-names></name>. <article-title>CNTNAP2 Is Significantly Associated With Speech Sound Disorder in the Chinese Han Population</article-title>. <source/>Journal of child neurology. <year>2015</year>;<volume>30</volume>(<issue>13</issue>):<fpage>1806</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1177/0883073815581609</pub-id> .<pub-id pub-id-type="pmid">25895914</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref051">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Friedman</surname><given-names>JI</given-names></name>, <name><surname>Vrijenhoek</surname><given-names>T</given-names></name>, <name><surname>Markx</surname><given-names>S</given-names></name>, <name><surname>Janssen</surname><given-names>IM</given-names></name>, <name><surname>van der Vliet</surname><given-names>WA</given-names></name>, <name><surname>Faas</surname><given-names>BH</given-names></name>, <etal>et al</etal>
<article-title>CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy</article-title>. <source/>Molecular psychiatry. <year>2008</year>;<volume>13</volume>(<issue>3</issue>):<fpage>261</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002049</pub-id> .<pub-id pub-id-type="pmid">17646849</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref052">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Malhotra</surname><given-names>D</given-names></name>, <name><surname>McCarthy</surname><given-names>S</given-names></name>, <name><surname>Michaelson</surname><given-names>JJ</given-names></name>, <name><surname>Vacic</surname><given-names>V</given-names></name>, <name><surname>Burdick</surname><given-names>KE</given-names></name>, <name><surname>Yoon</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>High frequencies of de novo CNVs in bipolar disorder and schizophrenia</article-title>. <source/>Neuron. <year>2011</year>;<volume>72</volume>(<issue>6</issue>):<fpage>951</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.007</pub-id>
<pub-id pub-id-type="pmid">22196331</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref053">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>D</given-names></name>, <name><surname>Cheng</surname><given-names>L</given-names></name>, <name><surname>Qian</surname><given-names>Y</given-names></name>, <name><surname>Alliey-Rodriguez</surname><given-names>N</given-names></name>, <name><surname>Kelsoe</surname><given-names>JR</given-names></name>, <name><surname>Greenwood</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Singleton deletions throughout the genome increase risk of bipolar disorder</article-title>. <source/>Molecular psychiatry. <year>2009</year>;<volume>14</volume>(<issue>4</issue>):<fpage>376</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.144</pub-id>
<pub-id pub-id-type="pmid">19114987</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref054">
<label>54</label>
<mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>IS</given-names></name>, <name><surname>Carvalho</surname><given-names>CM</given-names></name>, <name><surname>Douvaras</surname><given-names>P</given-names></name>, <name><surname>Ho</surname><given-names>SM</given-names></name>, <name><surname>Hartley</surname><given-names>BJ</given-names></name>, <name><surname>Zuccherato</surname><given-names>LW</given-names></name>, <etal>et al</etal>
<article-title>Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells</article-title>. <source/>NPJ schizophrenia. <year>2015</year>;<volume>1</volume>
<pub-id pub-id-type="doi">10.1038/npjschz.2015.19</pub-id>
<pub-id pub-id-type="pmid">26985448</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref055">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Elia</surname><given-names>J</given-names></name>, <name><surname>Gai</surname><given-names>X</given-names></name>, <name><surname>Xie</surname><given-names>HM</given-names></name>, <name><surname>Perin</surname><given-names>JC</given-names></name>, <name><surname>Geiger</surname><given-names>E</given-names></name>, <name><surname>Glessner</surname><given-names>JT</given-names></name>, <etal>et al</etal>
<article-title>Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes</article-title>. <source/>Molecular psychiatry. <year>2010</year>;<volume>15</volume>(<issue>6</issue>):<fpage>637</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.57</pub-id>
<pub-id pub-id-type="pmid">19546859</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref056">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Mefford</surname><given-names>HC</given-names></name>, <name><surname>Muhle</surname><given-names>H</given-names></name>, <name><surname>Ostertag</surname><given-names>P</given-names></name>, <name><surname>von Spiczak</surname><given-names>S</given-names></name>, <name><surname>Buysse</surname><given-names>K</given-names></name>, <name><surname>Baker</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies</article-title>. <source/>PLoS genetics. <year>2010</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e1000962</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000962</pub-id>
<pub-id pub-id-type="pmid">20502679</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref057">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>Lesca</surname><given-names>G</given-names></name>, <name><surname>Rudolf</surname><given-names>G</given-names></name>, <name><surname>Labalme</surname><given-names>A</given-names></name>, <name><surname>Hirsch</surname><given-names>E</given-names></name>, <name><surname>Arzimanoglou</surname><given-names>A</given-names></name>, <name><surname>Genton</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism</article-title>. <source/>Epilepsia. <year>2012</year>;<volume>53</volume>(<issue>9</issue>):<fpage>1526</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03559.x</pub-id> .<pub-id pub-id-type="pmid">22738016</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref058">
<label>58</label>
<mixed-citation publication-type="journal"><name><surname>Curran</surname><given-names>S</given-names></name>, <name><surname>Ahn</surname><given-names>JW</given-names></name>, <name><surname>Grayton</surname><given-names>H</given-names></name>, <name><surname>Collier</surname><given-names>DA</given-names></name>, <name><surname>Ogilvie</surname><given-names>CM</given-names></name>. <article-title>NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series—further understanding of the relevance of NRXN1 to neurodevelopmental disorders</article-title>. <source/>Journal of molecular psychiatry. <year>2013</year>;<volume>1</volume>(<issue>1</issue>):<fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/2049-9256-1-4</pub-id>
<pub-id pub-id-type="pmid">25408897</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref059">
<label>59</label>
<mixed-citation publication-type="journal"><name><surname>Pippucci</surname><given-names>T</given-names></name>, <name><surname>Licchetta</surname><given-names>L</given-names></name>, <name><surname>Baldassari</surname><given-names>S</given-names></name>, <name><surname>Palombo</surname><given-names>F</given-names></name>, <name><surname>Menghi</surname><given-names>V</given-names></name>, <name><surname>D'Aurizio</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Epilepsy with auditory features: A heterogeneous clinico-molecular disease</article-title>. <source/>Neurology Genetics. <year>2015</year>;<volume>1</volume>(<issue>1</issue>):<fpage>e5</fpage>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000005</pub-id>
<pub-id pub-id-type="pmid">27066544</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref060">
<label>60</label>
<mixed-citation publication-type="journal"><name><surname>Verkerk</surname><given-names>AJ</given-names></name>, <name><surname>Mathews</surname><given-names>CA</given-names></name>, <name><surname>Joosse</surname><given-names>M</given-names></name>, <name><surname>Eussen</surname><given-names>BH</given-names></name>, <name><surname>Heutink</surname><given-names>P</given-names></name>, <name><surname>Oostra</surname><given-names>BA</given-names></name>, <etal>et al</etal>
<article-title>CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder</article-title>. <source/>Genomics. <year>2003</year>;<volume>82</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>. .<pub-id pub-id-type="pmid">12809671</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref061">
<label>61</label>
<mixed-citation publication-type="journal"><name><surname>Hoyer</surname><given-names>H</given-names></name>, <name><surname>Braathen</surname><given-names>GJ</given-names></name>, <name><surname>Eek</surname><given-names>AK</given-names></name>, <name><surname>Nordang</surname><given-names>GB</given-names></name>, <name><surname>Skjelbred</surname><given-names>CF</given-names></name>, <name><surname>Russell</surname><given-names>MB</given-names></name>. <article-title>Copy number variations in a population-based study of Charcot-Marie-Tooth disease</article-title>. <source/>BioMed research international. <year>2015</year>;<volume>2015</volume>:<fpage>960404</fpage>
<pub-id pub-id-type="doi">10.1155/2015/960404</pub-id>
<pub-id pub-id-type="pmid">25648254</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref062">
<label>62</label>
<mixed-citation publication-type="journal"><name><surname>Al-Murrani</surname><given-names>A</given-names></name>, <name><surname>Ashton</surname><given-names>F</given-names></name>, <name><surname>Aftimos</surname><given-names>S</given-names></name>, <name><surname>George</surname><given-names>AM</given-names></name>, <name><surname>Love</surname><given-names>DR</given-names></name>. <article-title>Amino-Terminal Microdeletion within the CNTNAP2 Gene Associated with Variable Expressivity of Speech Delay</article-title>. <source/>Case reports in genetics. <year>2012</year>;<volume>2012</volume>:<fpage>172408</fpage>
<pub-id pub-id-type="doi">10.1155/2012/172408</pub-id>
<pub-id pub-id-type="pmid">23074684</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref063">
<label>63</label>
<mixed-citation publication-type="journal"><name><surname>Centanni</surname><given-names>TM</given-names></name>, <name><surname>Sanmann</surname><given-names>JN</given-names></name>, <name><surname>Green</surname><given-names>JR</given-names></name>, <name><surname>Iuzzini-Seigel</surname><given-names>J</given-names></name>, <name><surname>Bartlett</surname><given-names>C</given-names></name>, <name><surname>Sanger</surname><given-names>WG</given-names></name>, <etal>et al</etal>
<article-title>The role of candidate-gene CNTNAP2 in childhood apraxia of speech and specific language impairment</article-title>. <source/>American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. <year>2015</year>;<volume>168</volume>(<issue>7</issue>):<fpage>536</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32325</pub-id> .<pub-id pub-id-type="pmid">26097074</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref064">
<label>64</label>
<mixed-citation publication-type="journal"><name><surname>Laffin</surname><given-names>JJ</given-names></name>, <name><surname>Raca</surname><given-names>G</given-names></name>, <name><surname>Jackson</surname><given-names>CA</given-names></name>, <name><surname>Strand</surname><given-names>EA</given-names></name>, <name><surname>Jakielski</surname><given-names>KJ</given-names></name>, <name><surname>Shriberg</surname><given-names>LD</given-names></name>. <article-title>Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization</article-title>. <source/>Genetics in medicine: official journal of the American College of Medical Genetics. <year>2012</year>;<volume>14</volume>(<issue>11</issue>):<fpage>928</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2012.72</pub-id>
<pub-id pub-id-type="pmid">22766611</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref065">
<label>65</label>
<mixed-citation publication-type="journal"><name><surname>Veerappa</surname><given-names>AM</given-names></name>, <name><surname>Saldanha</surname><given-names>M</given-names></name>, <name><surname>Padakannaya</surname><given-names>P</given-names></name>, <name><surname>Ramachandra</surname><given-names>NB</given-names></name>. <article-title>Family-based genome-wide copy number scan identifies five new genes of dyslexia involved in dendritic spinal plasticity</article-title>. <source/>Journal of human genetics. <year>2013</year>;<volume>58</volume>(<issue>8</issue>):<fpage>539</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2013.47</pub-id> .<pub-id pub-id-type="pmid">23677055</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref066">
<label>66</label>
<mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>YT</given-names></name>, <name><surname>Chen</surname><given-names>PC</given-names></name>, <name><surname>Tsai</surname><given-names>IJ</given-names></name>, <name><surname>Sung</surname><given-names>FC</given-names></name>, <name><surname>Chin</surname><given-names>ZN</given-names></name>, <name><surname>Kuo</surname><given-names>HT</given-names></name>, <etal>et al</etal>
<article-title>Bidirectional relation between schizophrenia and epilepsy: a population-based retrospective cohort study</article-title>. <source/>Epilepsia. <year>2011</year>;<volume>52</volume>(<issue>11</issue>):<fpage>2036</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03268.x</pub-id> .<pub-id pub-id-type="pmid">21929680</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref067">
<label>67</label>
<mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>HJ</given-names></name>, <name><surname>Liao</surname><given-names>CC</given-names></name>, <name><surname>Hu</surname><given-names>CJ</given-names></name>, <name><surname>Shen</surname><given-names>WW</given-names></name>, <name><surname>Chen</surname><given-names>TL</given-names></name>. <article-title>Psychiatric disorders after epilepsy diagnosis: a population-based retrospective cohort study</article-title>. <source/>PloS one. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e59999</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0059999</pub-id>
<pub-id pub-id-type="pmid">23577079</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref068">
<label>68</label>
<mixed-citation publication-type="journal"><name><surname>Sucksdorff</surname><given-names>D</given-names></name>, <name><surname>Brown</surname><given-names>AS</given-names></name>, <name><surname>Chudal</surname><given-names>R</given-names></name>, <name><surname>Jokiranta-Olkoniemi</surname><given-names>E</given-names></name>, <name><surname>Leivonen</surname><given-names>S</given-names></name>, <name><surname>Suominen</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Parental and comorbid epilepsy in persons with bipolar disorder</article-title>. <source/>Journal of affective disorders. <year>2015</year>;<volume>188</volume>:<fpage>107</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2015.08.051</pub-id>
<pub-id pub-id-type="pmid">26356289</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref069">
<label>69</label>
<mixed-citation publication-type="journal"><name><surname>Wiglusz</surname><given-names>MS</given-names></name>, <name><surname>Landowski</surname><given-names>J</given-names></name>, <name><surname>Cubala</surname><given-names>WJ</given-names></name>, <name><surname>Agius</surname><given-names>M</given-names></name>. <article-title>Overlapping phenomena of bipolar disorder and epilepsy—a common pharmacological pathway</article-title>. <source/>Psychiatria Danubina. <year>2015</year>;<volume>27</volume>
<issue>Suppl 1</issue>:<fpage>S177</fpage>–<lpage>81</lpage>. .<pub-id pub-id-type="pmid">26417756</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref070">
<label>70</label>
<mixed-citation publication-type="journal"><name><surname>Tuchman</surname><given-names>R</given-names></name>, <name><surname>Rapin</surname><given-names>I</given-names></name>. <article-title>Epilepsy in autism</article-title>. <source/>The Lancet Neurology. <year>2002</year>;<volume>1</volume>(<issue>6</issue>):<fpage>352</fpage>–<lpage>8</lpage>. .<pub-id pub-id-type="pmid">12849396</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref071">
<label>71</label>
<mixed-citation publication-type="journal"><name><surname>Besag</surname><given-names>FM</given-names></name>. <article-title>Epilepsy in patients with autism: links, risks and treatment challenges</article-title>. <source/>Neuropsychiatric disease and treatment. <year>2018</year>;<volume>14</volume>:<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S120509</pub-id>
<pub-id pub-id-type="pmid">29296085</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref072">
<label>72</label>
<mixed-citation publication-type="journal"><name><surname>Wells</surname><given-names>R</given-names></name>, <name><surname>Swaminathan</surname><given-names>V</given-names></name>, <name><surname>Sundram</surname><given-names>S</given-names></name>, <name><surname>Weinberg</surname><given-names>D</given-names></name>, <name><surname>Bruggemann</surname><given-names>J</given-names></name>, <name><surname>Jacomb</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes</article-title>. <source/>NPJ schizophrenia. <year>2015</year>;<volume>1</volume>:<fpage>15043</fpage>
<pub-id pub-id-type="doi">10.1038/npjschz.2015.43</pub-id>
<pub-id pub-id-type="pmid">27336046</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref073">
<label>73</label>
<mixed-citation publication-type="journal"><name><surname>Pawelczyk</surname><given-names>A</given-names></name>, <name><surname>Kotlicka-Antczak</surname><given-names>M</given-names></name>, <name><surname>Lojek</surname><given-names>E</given-names></name>, <name><surname>Ruszpel</surname><given-names>A</given-names></name>, <name><surname>Pawelczyk</surname><given-names>T</given-names></name>. <article-title>Schizophrenia patients have higher-order language and extralinguistic impairments</article-title>. <source/>Schizophrenia research. <year>2018</year>;<volume>192</volume>:<fpage>274</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2017.04.030</pub-id> .<pub-id pub-id-type="pmid">28438437</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref074">
<label>74</label>
<mixed-citation publication-type="journal"><name><surname>Raucher-Chene</surname><given-names>D</given-names></name>, <name><surname>Achim</surname><given-names>AM</given-names></name>, <name><surname>Kaladjian</surname><given-names>A</given-names></name>, <name><surname>Besche-Richard</surname><given-names>C</given-names></name>. <article-title>Verbal fluency in bipolar disorders: A systematic review and meta-analysis</article-title>. <source/>Journal of affective disorders. <year>2017</year>;<volume>207</volume>:<fpage>359</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2016.09.039</pub-id> .<pub-id pub-id-type="pmid">27744224</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref075">
<label>75</label>
<mixed-citation publication-type="journal"><name><surname>Rapin</surname><given-names>I</given-names></name>, <name><surname>Dunn</surname><given-names>M</given-names></name>. <article-title>Update on the language disorders of individuals on the autistic spectrum</article-title>. <source/>Brain &amp; development. <year>2003</year>;<volume>25</volume>(<issue>3</issue>):<fpage>166</fpage>–<lpage>72</lpage>. .<pub-id pub-id-type="pmid">12689694</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref076">
<label>76</label>
<mixed-citation publication-type="journal"><name><surname>Tager-Flusberg</surname><given-names>H</given-names></name>, <name><surname>Calkins</surname><given-names>S</given-names></name>, <name><surname>Nolin</surname><given-names>T</given-names></name>, <name><surname>Baumberger</surname><given-names>T</given-names></name>, <name><surname>Anderson</surname><given-names>M</given-names></name>, <name><surname>Chadwick-Dias</surname><given-names>A</given-names></name>. <article-title>A longitudinal study of language acquisition in autistic and Down syndrome children</article-title>. <source/>Journal of autism and developmental disorders. <year>1990</year>;<volume>20</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>21</lpage>. .<pub-id pub-id-type="pmid">2139024</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref077">
<label>77</label>
<mixed-citation publication-type="journal"><name><surname>Fromer</surname><given-names>M</given-names></name>, <name><surname>Pocklington</surname><given-names>AJ</given-names></name>, <name><surname>Kavanagh</surname><given-names>DH</given-names></name>, <name><surname>Williams</surname><given-names>HJ</given-names></name>, <name><surname>Dwyer</surname><given-names>S</given-names></name>, <name><surname>Gormley</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>. <source/>Nature. <year>2014</year>;<volume>506</volume>(<issue>7487</issue>):<fpage>179</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1038/nature12929</pub-id>
<pub-id pub-id-type="pmid">24463507</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref078">
<label>78</label>
<mixed-citation publication-type="journal"><name><surname>Toma</surname><given-names>C</given-names></name>, <name><surname>Shaw</surname><given-names>AD</given-names></name>, <name><surname>Allcock</surname><given-names>RJN</given-names></name>, <name><surname>Heath</surname><given-names>A</given-names></name>, <name><surname>Pierce</surname><given-names>KD</given-names></name>, <name><surname>Mitchell</surname><given-names>PB</given-names></name>, <etal>et al</etal>
<article-title>An examination of multiple classes of rare variants in extended families with bipolar disorder</article-title>. <source/>Translational psychiatry. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>65</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-018-0113-y</pub-id> .<pub-id pub-id-type="pmid">29531218</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref079">
<label>79</label>
<mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>N</given-names></name>, <name><surname>Lee</surname><given-names>I</given-names></name>, <name><surname>Marcotte</surname><given-names>EM</given-names></name>, <name><surname>Hurles</surname><given-names>ME</given-names></name>. <article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>. <source/>PLoS genetics. <year>2010</year>;<volume>6</volume>(<issue>10</issue>):<fpage>e1001154</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1001154</pub-id>
<pub-id pub-id-type="pmid">20976243</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref080">
<label>80</label>
<mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>LA</given-names></name>, <name><surname>Del Bene</surname><given-names>VA</given-names></name>, <name><surname>Molholm</surname><given-names>S</given-names></name>, <name><surname>Jae Woo</surname><given-names>Y</given-names></name>, <name><surname>Andrade</surname><given-names>GN</given-names></name>, <name><surname>Abrahams</surname><given-names>BS</given-names></name>, <etal>et al</etal>
<article-title>Common variation in the autism risk gene CNTNAP2, brain structural connectivity and multisensory speech integration</article-title>. <source/>Brain and language. <year>2017</year>;<volume>174</volume>:<fpage>50</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.bandl.2017.07.005</pub-id> .<pub-id pub-id-type="pmid">28738218</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref081">
<label>81</label>
<mixed-citation publication-type="journal"><name><surname>Toma</surname><given-names>C</given-names></name>, <name><surname>Hervas</surname><given-names>A</given-names></name>, <name><surname>Torrico</surname><given-names>B</given-names></name>, <name><surname>Balmana</surname><given-names>N</given-names></name>, <name><surname>Salgado</surname><given-names>M</given-names></name>, <name><surname>Maristany</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2</article-title>. <source/>Psychiatric genetics. <year>2013</year>;<volume>23</volume>(<issue>2</issue>):<fpage>82</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32835d6fc6</pub-id> .<pub-id pub-id-type="pmid">23277129</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref082">
<label>82</label>
<mixed-citation publication-type="journal"><name><surname>Werling</surname><given-names>AM</given-names></name>, <name><surname>Bobrowski</surname><given-names>E</given-names></name>, <name><surname>Taurines</surname><given-names>R</given-names></name>, <name><surname>Gundelfinger</surname><given-names>R</given-names></name>, <name><surname>Romanos</surname><given-names>M</given-names></name>, <name><surname>Grunblatt</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>CNTNAP2 gene in high functioning autism: no association according to family and meta-analysis approaches</article-title>. <source/>J Neural Transm (Vienna). <year>2016</year>;<volume>123</volume>(<issue>3</issue>):<fpage>353</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-015-1458-5</pub-id> .<pub-id pub-id-type="pmid">26559825</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref083">
<label>83</label>
<mixed-citation publication-type="journal"><name><surname>Torrico</surname><given-names>B</given-names></name>, <name><surname>Chiocchetti</surname><given-names>AG</given-names></name>, <name><surname>Bacchelli</surname><given-names>E</given-names></name>, <name><surname>Trabetti</surname><given-names>E</given-names></name>, <name><surname>Hervas</surname><given-names>A</given-names></name>, <name><surname>Franke</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Lack of replication of previous autism spectrum disorder GWAS hits in European populations</article-title>. <source/>Autism Res. <year>2017</year>;<volume>10</volume>(<issue>2</issue>):<fpage>202</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1662</pub-id> .<pub-id pub-id-type="pmid">27417655</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref084">
<label>84</label>
<mixed-citation publication-type="journal"><name><surname>Murdoch</surname><given-names>JD</given-names></name>, <name><surname>Gupta</surname><given-names>AR</given-names></name>, <name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>Walker</surname><given-names>MF</given-names></name>, <name><surname>Keaney</surname><given-names>J</given-names></name>, <name><surname>Fernandez</surname><given-names>TV</given-names></name>, <etal>et al</etal>
<article-title>No evidence for association of autism with rare heterozygous point mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins</article-title>. <source/>PLoS genetics. <year>2015</year>;<volume>11</volume>(<issue>1</issue>):<fpage>e1004852</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004852</pub-id>
<pub-id pub-id-type="pmid">25621974</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref085">
<label>85</label>
<mixed-citation publication-type="journal"><name><surname>Canali</surname><given-names>G</given-names></name>, <name><surname>Garcia</surname><given-names>M</given-names></name>, <name><surname>Hivert</surname><given-names>B</given-names></name>, <name><surname>Pinatel</surname><given-names>D</given-names></name>, <name><surname>Goullancourt</surname><given-names>A</given-names></name>, <name><surname>Oguievetskaia</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Genetic variants in autism-related CNTNAP2 impair axonal growth of cortical neurons</article-title>. <source/>Human molecular genetics. <year>2018</year>;<volume>27</volume>(<issue>11</issue>):<fpage>1941</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy102</pub-id> .<pub-id pub-id-type="pmid">29788201</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref086">
<label>86</label>
<mixed-citation publication-type="journal"><name><surname>de Leeuw</surname><given-names>CA</given-names></name>, <name><surname>Mooij</surname><given-names>JM</given-names></name>, <name><surname>Heskes</surname><given-names>T</given-names></name>, <name><surname>Posthuma</surname><given-names>D</given-names></name>. <article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title>. <source/>PLoS computational biology. <year>2015</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e1004219</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1004219</pub-id>
<pub-id pub-id-type="pmid">25885710</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref087">
<label>87</label>
<mixed-citation publication-type="journal"><name><surname>Demontis</surname><given-names>D</given-names></name>, <name><surname>Walters</surname><given-names>RK</given-names></name>, <name><surname>Martin</surname><given-names>J</given-names></name>, <name><surname>Mattheisen</surname><given-names>M</given-names></name>, <name><surname>Als</surname><given-names>TD</given-names></name>, <name><surname>Agerbo</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Discovery Of The First Genome-Wide Significant Risk Loci For ADHD</article-title>. <source/>bioRxiv. <year>2017</year>
<pub-id pub-id-type="doi">10.1101/145581</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref088">
<label>88</label>
<mixed-citation publication-type="journal"><collab>Autism Spectrum Disorders Working Group of The Psychiatric Genomics C</collab>. <article-title>Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia</article-title>. <source/>Molecular autism. <year>2017</year>;<volume>8</volume>:<fpage>21</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-017-0137-9</pub-id>
<pub-id pub-id-type="pmid">28540026</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref089">
<label>89</label>
<mixed-citation publication-type="journal"><collab>Major Depressive Disorder Working Group of the Psychiatric GC</collab>, <name><surname>Ripke</surname><given-names>S</given-names></name>, <name><surname>Wray</surname><given-names>NR</given-names></name>, <name><surname>Lewis</surname><given-names>CM</given-names></name>, <name><surname>Hamilton</surname><given-names>SP</given-names></name>, <name><surname>Weissman</surname><given-names>MM</given-names></name>, <etal>et al</etal>
<article-title>A mega-analysis of genome-wide association studies for major depressive disorder</article-title>. <source/>Molecular psychiatry. <year>2013</year>;<volume>18</volume>(<issue>4</issue>):<fpage>497</fpage>–<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.21</pub-id>
<pub-id pub-id-type="pmid">22472876</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref090">
<label>90</label>
<mixed-citation publication-type="journal"><collab>Schizophrenia Working Group of the Psychiatric Genomics C</collab>. <article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source/>Nature. <year>2014</year>;<volume>511</volume>(<issue>7510</issue>):<fpage>421</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
<pub-id pub-id-type="pmid">25056061</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref091">
<label>91</label>
<mixed-citation publication-type="journal"><name><surname>Stahl</surname><given-names>E</given-names></name>, <name><surname>Forstner</surname><given-names>A</given-names></name>, <name><surname>McQuillin</surname><given-names>A</given-names></name>, <name><surname>Ripke</surname><given-names>S</given-names></name>, <name><surname>Ophoff</surname><given-names>R</given-names></name>, <name><surname>Scott</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Genomewide association study identifies 30 loci associated with bipolar disorder</article-title>. <source/>bioRxiv. <year>2017</year>
<pub-id pub-id-type="doi">10.1101/173062</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref092">
<label>92</label>
<mixed-citation publication-type="journal"><collab>International Obsessive Compulsive Disorder Foundation Genetics C, Studies OCDCGA</collab>. <article-title>Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis</article-title>. <source/>Molecular psychiatry. <year>2018</year>;<volume>23</volume>(<issue>5</issue>):<fpage>1181</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2017.154</pub-id> .<pub-id pub-id-type="pmid">28761083</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref093">
<label>93</label>
<mixed-citation publication-type="journal"><name><surname>Duncan</surname><given-names>L</given-names></name>, <name><surname>Yilmaz</surname><given-names>Z</given-names></name>, <name><surname>Gaspar</surname><given-names>H</given-names></name>, <name><surname>Walters</surname><given-names>R</given-names></name>, <name><surname>Goldstein</surname><given-names>J</given-names></name>, <name><surname>Anttila</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa</article-title>. <source/>The American journal of psychiatry. <year>2017</year>;<volume>174</volume>(<issue>9</issue>):<fpage>850</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2017.16121402</pub-id>
<pub-id pub-id-type="pmid">28494655</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref094">
<label>94</label>
<mixed-citation publication-type="journal"><name><surname>Purcell</surname><given-names>S</given-names></name>, <name><surname>Neale</surname><given-names>B</given-names></name>, <name><surname>Todd-Brown</surname><given-names>K</given-names></name>, <name><surname>Thomas</surname><given-names>L</given-names></name>, <name><surname>Ferreira</surname><given-names>MA</given-names></name>, <name><surname>Bender</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source/>American journal of human genetics. <year>2007</year>;<volume>81</volume>(<issue>3</issue>):<fpage>559</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref095">
<label>95</label>
<mixed-citation publication-type="journal"><name><surname>Dopazo</surname><given-names>J</given-names></name>, <name><surname>Amadoz</surname><given-names>A</given-names></name>, <name><surname>Bleda</surname><given-names>M</given-names></name>, <name><surname>Garcia-Alonso</surname><given-names>L</given-names></name>, <name><surname>Aleman</surname><given-names>A</given-names></name>, <name><surname>Garcia-Garcia</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation</article-title>. <source/>Molecular biology and evolution. <year>2016</year>;<volume>33</volume>(<issue>5</issue>):<fpage>1205</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msw005</pub-id>
<pub-id pub-id-type="pmid">26764160</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref096">
<label>96</label>
<mixed-citation publication-type="journal"><name><surname>Puente</surname><given-names>XS</given-names></name>, <name><surname>Bea</surname><given-names>S</given-names></name>, <name><surname>Valdes-Mas</surname><given-names>R</given-names></name>, <name><surname>Villamor</surname><given-names>N</given-names></name>, <name><surname>Gutierrez-Abril</surname><given-names>J</given-names></name>, <name><surname>Martin-Subero</surname><given-names>JI</given-names></name>, <etal>et al</etal>
<article-title>Non-coding recurrent mutations in chronic lymphocytic leukaemia</article-title>. <source/>Nature. <year>2015</year>;<volume>526</volume>(<issue>7574</issue>):<fpage>519</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/nature14666</pub-id> .<pub-id pub-id-type="pmid">26200345</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref097">
<label>97</label>
<mixed-citation publication-type="journal"><name><surname>Toma</surname><given-names>C</given-names></name>, <name><surname>Torrico</surname><given-names>B</given-names></name>, <name><surname>Hervas</surname><given-names>A</given-names></name>, <name><surname>Valdes-Mas</surname><given-names>R</given-names></name>, <name><surname>Tristan-Noguero</surname><given-names>A</given-names></name>, <name><surname>Padillo</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations</article-title>. <source/>Molecular psychiatry. <year>2014</year>;<volume>19</volume>(<issue>7</issue>):<fpage>784</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.106</pub-id> .<pub-id pub-id-type="pmid">23999528</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref098">
<label>98</label>
<mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Cai</surname><given-names>T</given-names></name>, <name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>. <source/>Molecular psychiatry. <year>2016</year>;<volume>21</volume>(<issue>2</issue>):<fpage>290</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.40</pub-id>
<pub-id pub-id-type="pmid">25849321</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref099">
<label>99</label>
<mixed-citation publication-type="journal"><name><surname>Turner</surname><given-names>TN</given-names></name>, <name><surname>Yi</surname><given-names>Q</given-names></name>, <name><surname>Krumm</surname><given-names>N</given-names></name>, <name><surname>Huddleston</surname><given-names>J</given-names></name>, <name><surname>Hoekzema</surname><given-names>K</given-names></name>, <name><surname>HA</surname><given-names>FS</given-names></name>, <etal>et al</etal>
<article-title>denovo-db: a compendium of human de novo variants</article-title>. <source/>Nucleic acids research. <year>2017</year>;<volume>45</volume>(<issue>D1</issue>):<fpage>D804</fpage>–<lpage>D11</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw865</pub-id>
<pub-id pub-id-type="pmid">27907889</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref100">
<label>100</label>
<mixed-citation publication-type="journal"><name><surname>Adams</surname><given-names>LJ</given-names></name>, <name><surname>Mitchell</surname><given-names>PB</given-names></name>, <name><surname>Fielder</surname><given-names>SL</given-names></name>, <name><surname>Rosso</surname><given-names>A</given-names></name>, <name><surname>Donald</surname><given-names>JA</given-names></name>, <name><surname>Schofield</surname><given-names>PR</given-names></name>. <article-title>A susceptibility locus for bipolar affective disorder on chromosome 4q35</article-title>. <source/>Am J Hum Genet. <year>1998</year>;<volume>62</volume>(<issue>5</issue>):<fpage>1084</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1086/301826</pub-id> .<pub-id pub-id-type="pmid">9545396</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref101">
<label>101</label>
<mixed-citation publication-type="journal"><name><surname>Badenhop</surname><given-names>RF</given-names></name>, <name><surname>Moses</surname><given-names>MJ</given-names></name>, <name><surname>Scimone</surname><given-names>A</given-names></name>, <name><surname>Adams</surname><given-names>LJ</given-names></name>, <name><surname>Kwok</surname><given-names>JB</given-names></name>, <name><surname>Jones</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Genetic refinement and physical mapping of a 2.3 Mb probable disease region associated with a bipolar affective disorder susceptibility locus on chromosome 4q35</article-title>. <source/>Am J Med Genet B Neuropsychiatr Genet. <year>2003</year>;<volume>117</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.10023</pub-id> .<pub-id pub-id-type="pmid">12555231</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref102">
<label>102</label>
<mixed-citation publication-type="journal"><name><surname>Fullerton</surname><given-names>JM</given-names></name>, <name><surname>Donald</surname><given-names>JA</given-names></name>, <name><surname>Mitchell</surname><given-names>PB</given-names></name>, <name><surname>Schofield</surname><given-names>PR</given-names></name>. <article-title>Two-Dimensional Genome Scan Identifies Multiple Genetic Interactions in Bipolar Affective Disorder</article-title>. <source/>Biol Psychiatry. <year>2010</year>;<volume>67</volume>(<issue>5</issue>):<fpage>478</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.10.022</pub-id> .<pub-id pub-id-type="pmid">20022591</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref103">
<label>103</label>
<mixed-citation publication-type="journal"><name><surname>Fullerton</surname><given-names>JM</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Badenhop</surname><given-names>RF</given-names></name>, <name><surname>Scimone</surname><given-names>A</given-names></name>, <name><surname>Blair</surname><given-names>IP</given-names></name>, <name><surname>Van Herten</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Genome screen of 15 Australian bipolar affective disorder pedigrees supports previously identified loci for bipolar susceptibility genes</article-title>. <source/>Psychiatr Genet. <year>2008</year>;<volume>18</volume>(<issue>4</issue>):<fpage>156</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e3282fa1861</pub-id> .<pub-id pub-id-type="pmid">18628676</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref104">
<label>104</label>
<mixed-citation publication-type="journal"><name><surname>McAuley</surname><given-names>EZ</given-names></name>, <name><surname>Blair</surname><given-names>IP</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Fullerton</surname><given-names>JM</given-names></name>, <name><surname>Scimone</surname><given-names>A</given-names></name>, <name><surname>Van Herten</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>A genome screen of 35 bipolar affective disorder pedigrees provides significant evidence for a susceptibility locus on chromosome 15q25-26</article-title>. <source/>Mol Psychiatry. <year>2009</year>;<volume>14</volume>(<issue>5</issue>):<fpage>492</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002146</pub-id> .<pub-id pub-id-type="pmid">18227837</pub-id></mixed-citation>
</ref>
<ref id="pgen.1007535.ref105">
<label>105</label>
<mixed-citation publication-type="other">National Institute of Mental Health. NIMH Genetics Initiative: Family Interview for Genetic Studies (FIGS). Rockville, MD1992.</mixed-citation>
</ref>
<ref id="pgen.1007535.ref106">
<label>106</label>
<mixed-citation publication-type="journal"><name><surname>Nurnberger</surname><given-names>JI</given-names><suffix>Jr.</suffix></name>, <name><surname>Blehar</surname><given-names>MC</given-names></name>, <name><surname>Kaufmann</surname><given-names>CA</given-names></name>, <name><surname>York-Cooler</surname><given-names>C</given-names></name>, <name><surname>Simpson</surname><given-names>SG</given-names></name>, <name><surname>Harkavy-Friedman</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative</article-title>. <source/>Archives of general psychiatry. <year>1994</year>;<volume>51</volume>(<issue>11</issue>):<fpage>849</fpage>–<lpage>59</lpage>; discussion 63–4. .<pub-id pub-id-type="pmid">7944874</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>